JP2011006371A - External preparation for skin - Google Patents
External preparation for skin Download PDFInfo
- Publication number
- JP2011006371A JP2011006371A JP2009153988A JP2009153988A JP2011006371A JP 2011006371 A JP2011006371 A JP 2011006371A JP 2009153988 A JP2009153988 A JP 2009153988A JP 2009153988 A JP2009153988 A JP 2009153988A JP 2011006371 A JP2011006371 A JP 2011006371A
- Authority
- JP
- Japan
- Prior art keywords
- external preparation
- skin
- acid
- mass
- skin external
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 71
- -1 polyethylene Polymers 0.000 claims abstract description 33
- 229920001577 copolymer Polymers 0.000 claims abstract description 26
- 229940061720 alpha hydroxy acid Drugs 0.000 claims abstract description 18
- 150000001280 alpha hydroxy acids Chemical class 0.000 claims abstract description 18
- 239000002562 thickening agent Substances 0.000 claims abstract description 17
- 239000000126 substance Substances 0.000 claims abstract description 14
- 239000005057 Hexamethylene diisocyanate Substances 0.000 claims abstract description 11
- 239000004698 Polyethylene Substances 0.000 claims abstract description 6
- 229920000573 polyethylene Polymers 0.000 claims abstract description 6
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 claims abstract description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 18
- 239000002537 cosmetic Substances 0.000 claims description 16
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000006071 cream Substances 0.000 claims description 10
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 8
- 125000002947 alkylene group Chemical group 0.000 claims description 7
- 150000002430 hydrocarbons Chemical group 0.000 claims description 5
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical group C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 2
- 238000005406 washing Methods 0.000 abstract description 14
- 239000003795 chemical substances by application Substances 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 12
- 230000007794 irritation Effects 0.000 abstract description 5
- 206010000496 acne Diseases 0.000 abstract description 4
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 60
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 239000000284 extract Substances 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 239000003921 oil Substances 0.000 description 15
- 235000019198 oils Nutrition 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 238000011156 evaluation Methods 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 239000004166 Lanolin Substances 0.000 description 12
- 235000019388 lanolin Nutrition 0.000 description 12
- 229940039717 lanolin Drugs 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 239000004721 Polyphenylene oxide Substances 0.000 description 10
- 150000001298 alcohols Chemical class 0.000 description 10
- 229920000570 polyether Polymers 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 9
- 239000005056 polyisocyanate Substances 0.000 description 9
- 229920001228 polyisocyanate Polymers 0.000 description 9
- 229920001296 polysiloxane Polymers 0.000 description 9
- 239000001993 wax Substances 0.000 description 9
- 229920005862 polyol Polymers 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- 238000006116 polymerization reaction Methods 0.000 description 7
- 150000003077 polyols Chemical class 0.000 description 7
- 235000011121 sodium hydroxide Nutrition 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 5
- AWMVMTVKBNGEAK-UHFFFAOYSA-N Styrene oxide Chemical compound C1OC1C1=CC=CC=C1 AWMVMTVKBNGEAK-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000000686 essence Substances 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000006096 absorbing agent Substances 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000010419 fine particle Substances 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- 230000003472 neutralizing effect Effects 0.000 description 4
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 4
- 239000001509 sodium citrate Substances 0.000 description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 3
- WHNPOQXWAMXPTA-UHFFFAOYSA-N 3-methylbut-2-enamide Chemical compound CC(C)=CC(N)=O WHNPOQXWAMXPTA-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- 102000011782 Keratins Human genes 0.000 description 3
- 108010076876 Keratins Proteins 0.000 description 3
- 235000019482 Palm oil Nutrition 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000002540 palm oil Substances 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000036548 skin texture Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- ARXKVVRQIIOZGF-UHFFFAOYSA-N 1,2,4-butanetriol Chemical compound OCCC(O)CO ARXKVVRQIIOZGF-UHFFFAOYSA-N 0.000 description 2
- FJGNTEKSQVNVTJ-UHFFFAOYSA-N 1-deoxy-D-lyxitol Natural products CC(O)C(O)C(O)CO FJGNTEKSQVNVTJ-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Diphosphoinositol tetrakisphosphate Chemical compound OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
- 229930064664 L-arginine Natural products 0.000 description 2
- 235000014852 L-arginine Nutrition 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- 244000280244 Luffa acutangula Species 0.000 description 2
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241000218657 Picea Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 238000012644 addition polymerization Methods 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940100463 hexyl laurate Drugs 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 2
- 229940069445 licorice extract Drugs 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- SJOXEWUZWQYCGL-DVOMOZLQSA-N menthyl salicylate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-DVOMOZLQSA-N 0.000 description 2
- 229960004665 menthyl salicylate Drugs 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 2
- 229960000969 phenyl salicylate Drugs 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 235000011118 potassium hydroxide Nutrition 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- SJOXEWUZWQYCGL-UHFFFAOYSA-N salicylic acid menthyl ester Natural products CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-UHFFFAOYSA-N 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 2
- 229940082004 sodium laurate Drugs 0.000 description 2
- XZPFBBWPPPGSDO-UHFFFAOYSA-M sodium;n,n-dimethylprop-2-enamide;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].CN(C)C(=O)C=C.[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C XZPFBBWPPPGSDO-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- BUDRQJIYQOCVNK-UHFFFAOYSA-N (3-methyl-1-silylbutyl) 2,3-dimethoxy-3-(2-methoxyphenyl)prop-2-enoate Chemical compound CC(C)CC([SiH3])OC(=O)C(OC)=C(OC)C1=CC=CC=C1OC BUDRQJIYQOCVNK-UHFFFAOYSA-N 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- CWLGEPSKQDNHIO-JOBJLJCHSA-N (e)-n-[(e)-benzylideneamino]-1-phenylmethanimine Chemical compound C=1C=CC=CC=1/C=N/N=C/C1=CC=CC=C1 CWLGEPSKQDNHIO-JOBJLJCHSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
- YAXKTBLXMTYWDQ-UHFFFAOYSA-N 1,2,3-butanetriol Chemical compound CC(O)C(O)CO YAXKTBLXMTYWDQ-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- LUYHWJKHJNFYGV-UHFFFAOYSA-N 1,2-diisocyanato-3-phenylbenzene Chemical compound O=C=NC1=CC=CC(C=2C=CC=CC=2)=C1N=C=O LUYHWJKHJNFYGV-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- FUTGDWNFCMWSJT-UHFFFAOYSA-N 2,3-bis(14-methylpentadecanoyloxy)propyl 14-methylpentadecanoate Chemical compound CC(C)CCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCC(C)C FUTGDWNFCMWSJT-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- AIUFBIQURVCZNA-UHFFFAOYSA-N 2,4-dimethylpentane-2,3,4-triol Chemical compound CC(C)(O)C(O)C(C)(C)O AIUFBIQURVCZNA-UHFFFAOYSA-N 0.000 description 1
- 229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 description 1
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 description 1
- BCIUEFPXIZSSHQ-UHFFFAOYSA-N 2-ethylbutane-1,2,3-triol pentane-2,3,4-triol Chemical compound CC(C(C(C)O)O)O.C(C)C(CO)(C(C)O)O BCIUEFPXIZSSHQ-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- KKDLMTFRMQVLMO-UHFFFAOYSA-N 2-heptylundecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCC)CCCCCCCCC KKDLMTFRMQVLMO-UHFFFAOYSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- OGJDIJKJFYOENF-UHFFFAOYSA-N 2-hexyldecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC OGJDIJKJFYOENF-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- OOJRTGIXWIUBGG-UHFFFAOYSA-N 2-methylpropane-1,2,3-triol Chemical compound OCC(O)(C)CO OOJRTGIXWIUBGG-UHFFFAOYSA-N 0.000 description 1
- XATHTZNVYDUDGS-UHFFFAOYSA-N 2-octadecylpropane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCCCC(O)(CO)CO XATHTZNVYDUDGS-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- VHDMXHLHMMROPO-UHFFFAOYSA-N 3-deoxypentitol Chemical compound OCC(O)CC(O)CO VHDMXHLHMMROPO-UHFFFAOYSA-N 0.000 description 1
- QFZITDCVRJQLMZ-UHFFFAOYSA-N 3-methylbutane-1,2,3-triol Chemical compound CC(C)(O)C(O)CO QFZITDCVRJQLMZ-UHFFFAOYSA-N 0.000 description 1
- WHSXTWFYRGOBGO-UHFFFAOYSA-N 3-methylsalicylic acid Chemical compound CC1=CC=CC(C(O)=O)=C1O WHSXTWFYRGOBGO-UHFFFAOYSA-N 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- WMNORUTYNGVDKW-UHFFFAOYSA-N 4-ethyl-2-[(4-methoxyphenyl)methylidene]octanoic acid;octyl 3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=C(OC)C=C1.CCCCC(CC)CC(C(O)=O)=CC1=CC=C(OC)C=C1 WMNORUTYNGVDKW-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- BVNWQSXXRMNYKH-UHFFFAOYSA-N 4-phenyl-2h-benzotriazole Chemical compound C1=CC=CC=C1C1=CC=CC2=C1NN=N2 BVNWQSXXRMNYKH-UHFFFAOYSA-N 0.000 description 1
- FMYBGKLXXBSJKK-UHFFFAOYSA-N 4-propylheptane-3,4,5-triol Chemical compound CCCC(O)(C(O)CC)C(O)CC FMYBGKLXXBSJKK-UHFFFAOYSA-N 0.000 description 1
- MVJSIAIXMFGVSA-UHFFFAOYSA-N 6-(2-hexyldecoxy)-6-oxohexanoic acid Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCC(O)=O MVJSIAIXMFGVSA-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 241000254032 Acrididae Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 235000012137 Atriplex confertifolia Nutrition 0.000 description 1
- 244000266618 Atriplex confertifolia Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 241000422842 Chamaecyparis pisifera Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 241000511010 Eustoma Species 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 244000141009 Hypericum perforatum Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- 239000011837 N,N-methylenebisacrylamide Substances 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N N-methylaminoacetic acid Natural products C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 241000209490 Nymphaea Species 0.000 description 1
- 235000016791 Nymphaea odorata subsp odorata Nutrition 0.000 description 1
- OZQVHUNPTKJEHJ-UHFFFAOYSA-N OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CC(C(C(O)(C)C)(O)C)(O)C Chemical compound OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CC(C(C(O)(C)C)(O)C)(O)C OZQVHUNPTKJEHJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- DJWYOLJPSHDSAL-UHFFFAOYSA-N Pantethine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO DJWYOLJPSHDSAL-UHFFFAOYSA-N 0.000 description 1
- 235000010678 Paulownia tomentosa Nutrition 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- KYWSCMDFVARMPN-LCSVLAELSA-N Saikosaponin D Chemical compound O([C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@]([C@H]3[C@]([C@@H]4[C@@]([C@@]5(C[C@@H](O)[C@]67CO[C@]5([C@@H]6CC(C)(C)CC7)C=C4)C)(C)CC3)(C)CC2)(C)CO)O[C@@H]([C@@H]1O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KYWSCMDFVARMPN-LCSVLAELSA-N 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 239000006087 Silane Coupling Agent Substances 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 206010064127 Solar lentigo Diseases 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- TUYRNAGGIJZRNM-LBHUVFDKSA-N [(2s)-2-[(2r)-4-hexadecanoyloxy-3-hydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethyl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(OC(=O)CCCCCCCCCCCCCCC)=C1O TUYRNAGGIJZRNM-LBHUVFDKSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- FGEUKKGODAGXOD-FMIVXFBMSA-N cyclohexyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound C1=CC(OC)=CC=C1\C=C\C(=O)OC1CCCCC1 FGEUKKGODAGXOD-FMIVXFBMSA-N 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 125000005442 diisocyanate group Chemical group 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- CXPOFJRHCFPDRI-UHFFFAOYSA-N dodecylbenzene;sulfuric acid Chemical compound OS(O)(=O)=O.CCCCCCCCCCCCC1=CC=CC=C1 CXPOFJRHCFPDRI-UHFFFAOYSA-N 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- KCDAMWRCUXGACP-DHZHZOJOSA-N ethyl (e)-2-cyano-3-phenylprop-2-enoate Chemical compound CCOC(=O)C(\C#N)=C\C1=CC=CC=C1 KCDAMWRCUXGACP-DHZHZOJOSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- TUKWPCXMNZAXLO-UHFFFAOYSA-N ethyl 2-nonylsulfanyl-4-oxo-1h-pyrimidine-6-carboxylate Chemical compound CCCCCCCCCSC1=NC(=O)C=C(C(=O)OCC)N1 TUKWPCXMNZAXLO-UHFFFAOYSA-N 0.000 description 1
- XCRHYAQWBYDRGV-UHFFFAOYSA-N ethyl 3-(4-propan-2-ylphenyl)prop-2-enoate Chemical compound CCOC(=O)C=CC1=CC=C(C(C)C)C=C1 XCRHYAQWBYDRGV-UHFFFAOYSA-N 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 229940072117 fennel extract Drugs 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- TZQPAZWGRJYTLN-UHFFFAOYSA-N hexane-2,3,4,5-tetrol Chemical compound CC(O)C(O)C(O)C(C)O TZQPAZWGRJYTLN-UHFFFAOYSA-N 0.000 description 1
- QPNQLFAXFXPMSV-UHFFFAOYSA-N hexane-2,3,4-triol Chemical compound CCC(O)C(O)C(C)O QPNQLFAXFXPMSV-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N isopropyl alcohol Natural products CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- YKWKFUUHPFWRNV-UHFFFAOYSA-N methyl 3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC=C(C(C)C)C=C1C(C)C YKWKFUUHPFWRNV-UHFFFAOYSA-N 0.000 description 1
- PABHEXWDYRTPBQ-UHFFFAOYSA-N methyl 3-[2,5-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC(C(C)C)=CC=C1C(C)C PABHEXWDYRTPBQ-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- ZWLPBLYKEWSWPD-UHFFFAOYSA-N o-toluic acid Chemical compound CC1=CC=CC=C1C(O)=O ZWLPBLYKEWSWPD-UHFFFAOYSA-N 0.000 description 1
- UVPGECJLXBGLDW-UHFFFAOYSA-N octadecan-7-ol Chemical compound CCCCCCCCCCCC(O)CCCCCC UVPGECJLXBGLDW-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 235000008975 pantethine Nutrition 0.000 description 1
- 239000011581 pantethine Substances 0.000 description 1
- 229960000903 pantethine Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- MOIOWCZVZKHQIC-UHFFFAOYSA-N pentane-1,2,4-triol Chemical compound CC(O)CC(O)CO MOIOWCZVZKHQIC-UHFFFAOYSA-N 0.000 description 1
- 235000020737 peppermint extract Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- XATKDVHSLQMHSY-RMKNXTFCSA-N propan-2-yl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC=C(\C=C\C(=O)OC(C)C)C=C1 XATKDVHSLQMHSY-RMKNXTFCSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- WZXKPNYMUZGZIA-RMKNXTFCSA-N propyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCCOC(=O)\C=C\C1=CC=C(OC)C=C1 WZXKPNYMUZGZIA-RMKNXTFCSA-N 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 229930192014 saikosaponin Natural products 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- QXJQHYBHAIHNGG-UHFFFAOYSA-N trimethylolethane Chemical compound OCC(C)(CO)CO QXJQHYBHAIHNGG-UHFFFAOYSA-N 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 229960004418 trolamine Drugs 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/594—Mixtures of polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
本発明は皮膚外用剤に関し、さらに詳しくは、使用性および安定性に優れた、皮膚の改善、老化防止、皺の予防・改善等のための皮膚外用剤およびそれを含む化粧料キットに関するものである。 The present invention relates to an external preparation for skin, and more particularly, to an external preparation for skin for improving skin, preventing aging, preventing or improving wrinkles, and a cosmetic kit containing the same, which are excellent in usability and stability. is there.
近年、皮膚表面の古い角質層を剥離し、さらに新しい角質層を再生させて、表皮のターンオーバー(新陳代謝)を促進させる効果を有するとして、グリコール酸、乳酸、リンゴ酸または酒石酸のようなα−ヒドロキシ酸、サリチル酸、トリクロロ酢酸、フェノール等が、化粧品に代表される皮膚外用剤中に配合されている。また、それら化合物は、肌のきめ、くすみ、荒れ等を改善するのに用いられる他に、小皺やしみ、そばかす、肝斑、老人性色素斑などの各種色素沈着、座そう(ニキビ)、皮膚炎痕、火傷、熱傷、創傷およびそれらの瘢痕皮膚の皺とりまたはしみとりなどのためのケミカルピーリングに用いられている(例えば、特許文献1および2)。それらの薬剤によって肌のきめやくすみ、ニキビ等を改善するには薬剤が肌上にとどまっていることが好ましいが、従来のケミカルピーリング用の外用剤は、使用時にたれ落ちて使用性が悪いという問題があった。また、増粘させるために増粘剤を多く配合した場合には、除去する時に洗い流しにくいという問題があった。 In recent years, it has the effect of exfoliating the old stratum corneum on the skin surface and regenerating a new stratum corneum to promote epidermis turnover (metabolism). Hydroxy acid, salicylic acid, trichloroacetic acid, phenol and the like are blended in a skin external preparation represented by cosmetics. These compounds are used to improve skin texture, dullness, roughness, etc., as well as various pigmentations such as fine wrinkles, stains, freckles, liver spots, and senile pigment spots, acne, skin It is used for chemical peeling for burning scars, burns, burns, wounds and the removal or blotting of those scar skins (for example, Patent Documents 1 and 2). In order to improve skin texture, dullness, acne, etc. with these drugs, it is preferable that the drug stays on the skin, but conventional external preparations for chemical peeling say that they are dripping during use and have poor usability. There was a problem. Moreover, when a lot of thickeners are blended in order to increase the viscosity, there is a problem that it is difficult to wash away when removing.
α−ヒドロキシ酸等を含む外用剤に増粘剤を配合する技術としては、例えば、カルボキシビニルポリマーとα−ヒドロキシ酸とを特定の配合割合で配合させたり、またはα−ヒドロキシカルボン酸と、キサンタンガムのようなヘテロバイオ多糖ガムと、無機増粘剤と、ポリアクリルアミド等をそれぞれ特定の配合量で配合させることによって、α−ヒドロキシ酸を含む組成物において粘度を高める試みが知られている(特許文献3および4)。また、現在市販されているα−ヒドロキシ酸含有の外用剤は、増粘剤としてキサンタンガムまたはヒドロキシエチルセルロースが用いられている。 As a technique for blending a thickener with an external preparation containing α-hydroxy acid, for example, carboxyvinyl polymer and α-hydroxy acid are blended in a specific blending ratio, or α-hydroxycarboxylic acid and xanthan gum are used. An attempt to increase the viscosity of a composition containing an α-hydroxy acid by blending a heterobiopolysaccharide gum such as the above, an inorganic thickener, polyacrylamide and the like in specific amounts is known (patents). References 3 and 4). Moreover, the external preparation containing alpha-hydroxy acid currently marketed uses xanthan gum or hydroxyethyl cellulose as a thickener.
しかしながら、これらの従来公知の外用剤はいずれも粘度安定性が悪く、製造直後には高い粘度を有していても、保存中、特に高温での保存中に粘度が著しく低下するという問題があった。特に、α−ヒドロキシ酸等の化合物を高配合量で含み、かつ低pHである場合には、十分かつ安定な増粘をもたらすことはできなかった。また増粘剤の量を増やして製造時の粘度を高くしすぎると、その使用性が悪くなったり、肌から除去する場合に洗い流しにくいという問題もあった。 However, all of these conventionally known external preparations have poor viscosity stability, and even if they have a high viscosity immediately after production, there is a problem that the viscosity is remarkably lowered during storage, particularly during storage at high temperatures. It was. In particular, when a compound such as α-hydroxy acid is included at a high blending amount and has a low pH, sufficient and stable thickening cannot be achieved. Further, if the amount of the thickener is increased to increase the viscosity at the time of production, the usability is deteriorated, and there is a problem that it is difficult to wash away when removing from the skin.
本発明は、上記のような事情に鑑み、α−ヒドロキシ酸を含み、皮膚に塗布後除去する外用剤であって、低pHで粘度安定性がよく、使用性および安定性に優れた皮膚外用剤を提供することを目的とする。 In view of the circumstances as described above, the present invention is an external preparation containing α-hydroxy acid, which is removed after application to the skin, and has excellent viscosity stability at low pH, and is excellent in usability and stability. The purpose is to provide an agent.
本発明者らは、上記課題を達成すべく鋭意研究を重ねた結果、特定の増粘剤を組み合わせて配合することにより、たれ落ちのない適度な粘度を有しながらも洗い流しやすく、また塗布しやすいα−ヒドロキシ酸配合の皮膚外用剤とすることができることを見出し、本発明を完成するに至った。 As a result of intensive studies to achieve the above-mentioned problems, the present inventors have formulated a specific thickener in combination so that it can be easily washed out and applied while having an appropriate viscosity without dripping. It discovered that it could be set as the skin external preparation containing an easy alpha-hydroxy acid composition, and came to complete this invention.
本発明は、次の(a)〜(c)を含み、pHが2.0〜5.0であり、皮膚に塗布後除去することを特徴とする皮膚外用剤である。
(a)α−ヒドロキシ酸より選択される1種または2種以上を1.0〜7.0質量%
(b)架橋型N,N−ジメチルアクリルアミド−2−アクリルアミド−2−メチルプロパンスルホン酸ナトリウム共重合体を0.1〜3.0質量%
(c)下記の一般式(1)で表される化合物からなる会合性増粘剤を0.1〜3.0質量%
R1−{(O−R2)k−OCONH−R3[−NHCOO−(R4−O)n−R5]h}m …(1)
〔式中、R1は炭化水素基を表し、R2およびR4は互いに同一でも異なっても良い炭素数2〜4のアルキレン基、またはフェニルエチレン基を表し、R3はウレタン結合を有していても良い炭化水素基を表し、R5は分岐鎖または2級の炭化水素基を表し、mは2以上の数であり、hは1以上の数であり、kは1〜500の範囲の数,nは1〜200の範囲の数である。〕
The present invention is an external preparation for skin comprising the following (a) to (c), having a pH of 2.0 to 5.0 and being removed after application to the skin.
(A) 1.0-7.0 mass% of 1 type (s) or 2 or more types selected from alpha-hydroxy acid
(B) 0.1 to 3.0% by mass of a crosslinked N, N-dimethylacrylamide-2-acrylamido-2-methylpropanesulfonic acid sodium copolymer
(C) 0.1 to 3.0% by mass of an associative thickener comprising a compound represented by the following general formula (1)
R 1 -{(O-R 2 ) k-OCONH-R 3 [-NHCOO- (R 4 -O) n-R 5 ] h} m (1)
[Wherein R 1 represents a hydrocarbon group, R 2 and R 4 represent a C 2-4 alkylene group which may be the same or different from each other, or a phenylethylene group, and R 3 has a urethane bond. R 5 represents a branched or secondary hydrocarbon group, m is a number of 2 or more, h is a number of 1 or more, and k is in the range of 1 to 500. , N is a number in the range of 1 to 200. ]
また本発明は、上記の皮膚外用剤と、該皮膚外用剤の使用後に用いるマスクと、該マスクの使用後に用いる夜用クリームとを少なくとも備えてなることを特徴とする化粧料キットである。 In addition, the present invention is a cosmetic kit comprising at least the above-mentioned external preparation for skin, a mask used after using the external preparation for skin, and a night cream used after using the mask.
本発明によるα−ヒドロキシ酸配合の皮膚外用剤は、たれ落ちのない適度な粘度を有しながらも洗い流しやすく、また塗布しやすく、低刺激で安全性にも優れたものである。また、粘度安定性もよく、ケミカルピーリング特有の肌のきめやくすみ、ニキビ等の改善効果にも優れたものである。
また、酸化チタンをさらに配合することにより、塗布後、塗布している部位が目視で確認でき、洗い流し残りも確認できるものとなる。
The external preparation for skin containing α-hydroxy acid according to the present invention has an appropriate viscosity with no sagging and is easy to wash off, easy to apply, low in irritation and excellent in safety. In addition, it has good viscosity stability and is excellent in improving skin texture, dullness and acne peculiar to chemical peeling.
Further, by further blending titanium oxide, the applied part can be visually confirmed after application, and the remaining washing can also be confirmed.
本発明による化粧料キットは、上記皮膚外用剤と共に用いる化粧料を併せ備えたキットとすることにより、使用者がこの化粧料キットを用いることで上記本発明の皮膚外用剤の効果をより一層引き出すことができる。 The cosmetic kit according to the present invention is a kit including the cosmetic used together with the above-mentioned external preparation for skin, so that the user can further draw out the effect of the external preparation for skin of the present invention by using this cosmetic kit. be able to.
以下に、本発明の実施の形態について説明する。
((a)α−ヒドロキシ酸より選択される1種または2種以上)
本発明で用いられる(a)α−ヒドロキシ酸は、従来から、化粧料や洗浄剤の緩衝剤や中和剤として用いられており、また、角質の柔軟化または細胞賦活化等の目的で各種化粧料に配合されている。本発明の皮膚外用剤に配合されるα−ヒドロキシ酸としては、特に限定はされないが、例えば、グリコール酸、乳酸、リンゴ酸、酒石酸、クエン酸、グリセリン酸、ピルビン酸、マンデル酸等が挙げられる。中でも、グリコール酸、乳酸、リンゴ酸、または酒石酸が、表皮のターンオーバーを促進する効果に優れているので特に好ましく、その中でもグリコール酸が好ましい。本発明の皮膚外用剤中にはこれらのα−ヒドロキシ酸を単独で配合しても、または必要に応じて2種以上を組み合わせて配合してもよい。
Embodiments of the present invention will be described below.
((A) one or more selected from α-hydroxy acids)
The (a) α-hydroxy acid used in the present invention has been conventionally used as a buffer or neutralizing agent for cosmetics and detergents, and various kinds are used for the purpose of softening keratin or activating cells. It is blended in cosmetics. Although it does not specifically limit as alpha-hydroxy acid mix | blended with the skin external preparation of this invention, For example, glycolic acid, lactic acid, malic acid, tartaric acid, a citric acid, glyceric acid, pyruvic acid, mandelic acid etc. are mentioned. . Among them, glycolic acid, lactic acid, malic acid, or tartaric acid is particularly preferable because it has an excellent effect of promoting the turnover of the epidermis, and glycolic acid is particularly preferable. In the external preparation for skin of the present invention, these α-hydroxy acids may be blended alone or in combination of two or more as necessary.
本発明の皮膚外用剤における上記(a)成分の配合量は、皮膚外用剤全量に対して1.0〜7.0質量%であるが、好ましくは2.0〜6.0質量%であり、さらに好ましくは3.0〜5.0質量%である。1.0質量%未満では、十分なケミカルピーリングの効果をもたらすことができない場合があり、また7.0質量%を越えると、皮膚刺激が大きくなる。 The blending amount of the component (a) in the external preparation for skin of the present invention is 1.0 to 7.0% by mass, preferably 2.0 to 6.0% by mass, based on the total amount of external preparation for skin. More preferably, it is 3.0-5.0 mass%. If the amount is less than 1.0% by mass, sufficient chemical peeling effect may not be achieved. If the amount exceeds 7.0% by mass, skin irritation increases.
((b)架橋型N,N−ジメチルアクリルアミド−2−アクリルアミド−2−メチルプロパンスルホン酸ナトリウム共重合体)
本発明で用いられる成分(b)の架橋型N,N−ジメチルアクリルアミド−2−アクリルアミド−2−メチルプロパンスルホン酸ナトリウム共重合体としては、N,N−ジメチルアクリルアミド−2−アクリルアミド−2−メチルプロパンスルホン酸ナトリウム−N,N−メチレンビスアクリルアミド共重合体が好ましく、この共重合体は、(ジメチルアクリルアミド/アクリロイルジメチルタウリンNa)クロスポリマーとも称される。
(ジメチルアクリルアミド/アクリロイルジメチルタウリンNa)クロスポリマーは、特許第3708531号公報に記載された方法で製造することができる。
((B) Cross-linked N, N-dimethylacrylamide-2-acrylamido-2-methylpropanesulfonic acid sodium copolymer)
As the cross-linked sodium N, N-dimethylacrylamide-2-acrylamido-2-methylpropanesulfonate of component (b) used in the present invention, N, N-dimethylacrylamide-2-acrylamido-2-methyl Sodium propanesulfonate-N, N-methylenebisacrylamide copolymer is preferred, and this copolymer is also referred to as (dimethylacrylamide / acryloyldimethyltaurine Na) crosspolymer.
The (dimethylacrylamide / acryloyldimethyltaurine Na) crosspolymer can be produced by the method described in Japanese Patent No. 3708531.
本発明の皮膚外用剤における上記(b)成分の配合量は、皮膚外用剤全量に対して0.1〜3.0質量%であるが、好ましくは0.5〜2.0質量%であり、さらに好ましくは1.0〜1.5質量%である。(b)成分の配合量が少なすぎると粘度が低すぎて垂れ落ちしやすくなったり、あるいは(c)成分で粘度を確保した場合には塗布しにくくなる。(b)成分の配合量が多すぎると洗い流しにくくなる。 The blending amount of the component (b) in the external preparation for skin of the present invention is 0.1 to 3.0% by mass, preferably 0.5 to 2.0% by mass, based on the total amount of external preparation for skin. More preferably, it is 1.0-1.5 mass%. When the blending amount of the component (b) is too small, the viscosity is too low and it tends to sag, or when the viscosity is secured with the component (c), it becomes difficult to apply. (B) When there are too many compounding quantities of a component, it will become difficult to wash away.
((c)会合性増粘剤)
本発明で用いられる成分(c)の会合性増粘剤は、上記一般式(1)で表されるものである。
この会合性増粘剤は、親水基部を骨格とし、末端に疎水性部分をもつコポリマーであり、水溶性媒体中でコポリマーの疎水性部分同士が会合し増粘作用を示すものである。
((C) Associative thickener)
The associative thickener of component (c) used in the present invention is represented by the above general formula (1).
This associative thickener is a copolymer having a hydrophilic group as a skeleton and a hydrophobic portion at the terminal, and the hydrophobic portions of the copolymer are associated with each other in a water-soluble medium to exhibit a thickening action.
上記一般式(1)で表される疎水変性ポリウレタンは、例えばR1−[(O−R2)k−OH]mで表される1種または2種以上のポリエーテルポリオールとR3−(NCO)h+1で表される1種または2種以上のポリイソシアネートと、HO−(R4−O)n−R5で表される1種または2種以上のポリモノアルコールとを反応させることにより得ることができる。 The hydrophobic modified polyurethane represented by the above general formula (1) is, for example, one or two or more polyether polyols represented by R 1 -[(O—R 2 ) k—OH] m and R 3 — ( NCO) One or more polyisocyanates represented by h + 1 are reacted with one or more polymonoalcohols represented by HO— (R 4 —O) n—R 5 . Can be obtained.
この場合、一般式(1)中のR1〜R5は、用いるR1−[(O−R2)k−OH]m、R3(NCO)h+1、HO−(R4−O)n−R5により決定される。3者の仕込み比は、特に限定されないが、ポリエーテルポリオールおよびポリエーテルモノアルコール由来の水酸基と、ポリイソシアネート由来のイソシアネート基の比が、NCO/OH=0.8:1〜1.4:1であるのが好ましい。 In this case, R 1 to R 5 in the general formula (1) are R 1 -[(O—R 2 ) k—OH] m, R 3 (NCO) h + 1, HO— (R 4 —O) used. ) determined by n-R 5 . The charging ratio of the three members is not particularly limited, but the ratio of the hydroxyl group derived from polyether polyol and polyether monoalcohol to the isocyanate group derived from polyisocyanate is NCO / OH = 0.8: 1 to 1.4: 1. Is preferred.
一般式(1)で表される会合性増粘剤を得るのに好ましく用いることができるR1−[(O−R2)k−OH]mで表されるポリエーテルポリオール化合物は、m価のポリオールにエチレンオキイド、プロピレンオキサイド、ブチレンオキサイド、エピクロルヒドリン等のアルキレンオキサイド、スチレンオキサイド等を付加重合することによりできる。 The polyether polyol compound represented by R 1 — [(O—R 2 ) k—OH] m that can be preferably used to obtain the associative thickener represented by the general formula (1) has an m value of These polyols can be subjected to addition polymerization of alkylene oxides such as ethylene oxide, propylene oxide, butylene oxide, epichlorohydrin, styrene oxide, and the like.
ここでポリオールとしては、2〜8価のものが好ましく、例えばエチレングリコール、プロピレングリコール、ブチレングリコール、ヘキサメチレングリコール、ネオペンチルグリコール等の2価アルコール、グリセリン、トリオキシイソブタン、1,2,3−ブタントリオール、1,2,3−ペンタトリオール、2−メチル−1,2,3−プロパントリオール、2−メチル−2,3,4−ブタントリオール、2−エチル−1,2,3−ブタントリオール、2,3,4−ペンタントリオール、2,3,4−ヘキサントリオール、4−プロピル−3,4,5−ヘプタントリオール、2,4−ジメチル−2,3,4−ペンタントリオール、ペンタメチルグリセリン、ペンタグリセリン、1,2,4−ブタントリオール、1,2,4−ペンタントリオール、トリメチロールエタン、トリメチロールプロパン等の3価アルコール、ペンタエリスリトール、1,2,3,4−ペンタンテトロール、2,3,4,5−ヘキサンテトロール、1,2,4,5−ペンタンテトロール、1,3,4,5−ヘキサンテトロール等の4価のアルコール、アドニット、アラビット、キシリット等の5価アルコール、ジペンタエリスリトール、ソルビット、マンニット、イジット等の6価アルコール、ショ糖等の8価アルコール等が挙げられる。 Here, as the polyol, those having 2 to 8 valences are preferable. For example, dihydric alcohols such as ethylene glycol, propylene glycol, butylene glycol, hexamethylene glycol and neopentyl glycol, glycerin, trioxyisobutane and 1,2,3- Butanetriol, 1,2,3-pentatriol, 2-methyl-1,2,3-propanetriol, 2-methyl-2,3,4-butanetriol, 2-ethyl-1,2,3-butanetriol 2,3,4-pentanetriol, 2,3,4-hexanetriol, 4-propyl-3,4,5-heptanetriol, 2,4-dimethyl-2,3,4-pentanetriol, pentamethylglycerin Pentaglycerin, 1,2,4-butanetriol, 1,2,4-pentanetriol, trimethylolethane, Trihydric alcohols such as limethylolpropane, pentaerythritol, 1,2,3,4-pentanetetrol, 2,3,4,5-hexanetetrol, 1,2,4,5-pentanetetrol, 1, Tetravalent alcohols such as 3,4,5-hexanetetrol, pentahydric alcohols such as adnit, arabit, and xylit, hexavalent alcohols such as dipentaerythritol, sorbit, mannitol, and exit, and octavalent alcohols such as sucrose Etc.
また、付加させるアルキレンオキサイド、スチレンオキサイド等により、R2が決定され、特に入手が容易であり、優れた効果を発揮させるためには、炭素数2〜4のアルキレンオキサイドあるいはスチレンオキサイドが好ましい。 In addition, R 2 is determined by the alkylene oxide, styrene oxide, or the like to be added, and is particularly easily available. In order to exhibit an excellent effect, alkylene oxide or styrene oxide having 2 to 4 carbon atoms is preferable.
付加させるアルキレンオキサイド、スチレンオキサイド等は単独重合、2種類以上のランダム重合あるいはブロック重合であって良い。付加の方法は通常の方法であって良い。また、重合度kは、0〜1000であり、好ましくは1〜500、更に好ましくは10〜200が良い。また、R2に占めるエチレン基の割合が、好ましくは全R2の50〜100質量%であると、今回の目的に良好な会合性増粘剤が得られる。 Alkylene oxide, styrene oxide and the like to be added may be homopolymerization, two or more kinds of random polymerization, or block polymerization. The adding method may be a normal method. The degree of polymerization k is 0 to 1000, preferably 1 to 500, and more preferably 10 to 200. The ratio of ethylene group occupying the R 2 is preferably When it is 50 to 100 wt% of the total R 2, good associative thickener is obtained this purpose.
また、R1−[(O−R2)k−OH]mの分子量は500〜10万のものが好ましく、1000〜5万のものが特に好ましい。 Further, R 1 - molecular weight of [(O-R 2) k -OH] m is preferably from 500 to 100,000, particularly preferably from 1,000 to 50,000.
本発明の一般式(1)で表される疎水変性ポリエーテルウレタンを得るのに好ましく用いることができるR3−(NCO)h+1で表されるポリイソシアネートは、分子中に2個以上のイソシアネート基を有するものであれば特に限定されない。例えば、脂肪族ジイソシアネート、芳香族ジイソシアネート、脂環族ジイソシアネート、ビフェニルジイソシアネート、フェニルメタンのジイソシアネート、トリイソシアネート、テトライソシアネート等が挙げられる。 The polyisocyanate represented by R 3 — (NCO) h + 1 that can be preferably used to obtain the hydrophobically modified polyether urethane represented by the general formula (1) of the present invention comprises two or more polyisocyanates in the molecule. If it has an isocyanate group, it will not specifically limit. For example, aliphatic diisocyanate, aromatic diisocyanate, alicyclic diisocyanate, biphenyl diisocyanate, diisocyanate of phenylmethane, triisocyanate, tetraisocyanate and the like can be mentioned.
また、これらのポリイソシアネート化合物のダイマー、トリマー(イソシアヌレート結合)で用いられても良く、また、アミンと反応させてビウレットとして用いても良い。 Moreover, you may use with the dimer and trimer (isocyanurate coupling | bonding) of these polyisocyanate compounds, and you may make it react with an amine and use it as a biuret.
さらに、これらのポリイソシアネート化合物と、ポリオールを反応させたウレタン結合を有するポリイソシアネートも用いることができる。ポリオールとしては、2〜8価のものが好ましく、前述のポリオールが好ましい。なお、R3−(NCO)h+1として3価以上のポリイソシアネートを用いる場合は、このウレタン結合を有するポリイソシアネートが好ましい。 Further, polyisocyanates having urethane bonds obtained by reacting these polyisocyanate compounds with polyols can also be used. As a polyol, the thing of 2-8 valence is preferable, and the above-mentioned polyol is preferable. Incidentally, R 3 - (NCO) if the h + 1 using trivalent or more polyisocyanates, polyisocyanate preferably has the urethane bond.
本発明の一般式(1)で表される疎水性変性ポリエーテルウレタンを得るのに好ましく用いることができるHO−(R4−O)n−R5で表されるポリエーテルモノアルコールは、直鎖および分岐鎖または2級の1価アルコールのポリエーテルであれば特に限定されない。このような化合物は、直鎖および分岐鎖または2級の1価アルコールにエチレンオキサイド、プロピレンオキサイド、ブチレンオキサイド、エピクロルヒドリン等のアルキレンオキサイド、スチレンオキサイド等を付加重合することにより得ることができる。 The polyether monoalcohol represented by HO— (R 4 —O) n—R 5 that can be preferably used to obtain the hydrophobic modified polyether urethane represented by the general formula (1) of the present invention is The polyether is not particularly limited as long as it is a polyether of a chain and a branched chain or a secondary monohydric alcohol. Such a compound can be obtained by addition polymerization of alkylene oxide such as ethylene oxide, propylene oxide, butylene oxide, epichlorohydrin, styrene oxide or the like to a linear, branched or secondary monohydric alcohol.
上記の一般式(1)で表される化合物を製造する方法としては、通常のポリエーテルとイソシアネートとの反応と同様にして例えば80〜90℃ で1〜3時間加熱し、反応せしめて得ることができる。 As a method for producing the compound represented by the above general formula (1), it can be obtained by heating and reacting at 80 to 90 ° C. for 1 to 3 hours in the same manner as in the reaction of a normal polyether and isocyanate. Can do.
本発明において、最も好ましい(c)の会合性増粘剤は、(ポリエチレングリコール−240/デシルテトラデセス−20/ヘキサメチレンジイソシアネート)コポリマーである。(ポリエチレングリコール−240/デシルテトラデセス−20/ヘキサメチレンジイソシアネート)コポリマーは、ポリエチレングリコール−240/ヘキサメチレンジイソシアネートコポリマー ビスデシルテトラデセス−20エーテルとも称されるもので、市販品としてアデカノールGT−700(ADEKA社製)が挙げられる。 In the present invention, the most preferred associative thickener (c) is a (polyethylene glycol-240 / decyltetradeceth-20 / hexamethylene diisocyanate) copolymer. The (polyethylene glycol-240 / decyltetradeceth-20 / hexamethylene diisocyanate) copolymer is also referred to as polyethylene glycol-240 / hexamethylene diisocyanate copolymer bisdecyltetradeceth-20 ether. As a commercial product, Adecanol GT- 700 (made by ADEKA) is mentioned.
本発明の皮膚外用剤における上記(c)成分の配合量は、皮膚外用剤全量に対して0.1〜3.0質量%であるが、好ましくは0.5〜2.0質量%であり、さらに好ましくは1.0〜1.5質量%である。(c)成分の配合量が少なすぎると粘度が低すぎて垂れ落ちしやすくなったり、あるいは(b)成分で粘度を確保した場合には洗い流しにくくなる。(c)成分の配合量が多すぎると肌への塗布がしにくくなる。 The blending amount of the component (c) in the external preparation for skin of the present invention is 0.1 to 3.0% by mass, preferably 0.5 to 2.0% by mass, based on the total amount of external preparation for skin. More preferably, it is 1.0-1.5 mass%. If the blending amount of the component (c) is too small, the viscosity is too low and it tends to sag, or if the viscosity is secured with the component (b), it is difficult to wash away. When there is too much compounding quantity of (c) component, it will become difficult to apply to skin.
上記(b)成分と(c)成分の配合割合(質量比)は、(b):(c)=1:0.6〜1:1.5であることが好ましく、より好ましくは、(b):(c)=1:0.6〜1:1である。(b)成分に対して(c)成分が少なすぎると洗い流しにくくなり、(b)成分に対して(c)成分が多すぎると塗布しにくくなる。 The blending ratio (mass ratio) of the component (b) and the component (c) is preferably (b) :( c) = 1: 0.6 to 1: 1.5, more preferably (b ) :( c) = 1: 0.6 to 1: 1. If the amount of component (c) is too small relative to component (b), it will be difficult to wash away, and if the amount of component (c) is too large relative to component (b), it will be difficult to apply.
((d)酸化チタン)
本発明においては、(d)酸化チタンをさらに含むことにより、その着色効果で、塗布後、塗布している部位が目視で確認でき、洗い流し残りも確認できるものとなる。
本発明で用いられる皮膚外用剤は、α−ヒドロキシ酸を含み、ケミカルピーリング用として用いられることが好ましい。そのため、皮膚に適用後は一定時間経過後に除去するものであるが、基剤が透明の場合洗い流し残しや、拭き取り残しがわかりにくく、刺激の原因となる。
本発明に用いられる(d)酸化チタンとしては、通常、化粧料分野で使用されているものを用いることができる。
((D) titanium oxide)
In the present invention, by further including (d) titanium oxide, the applied part can be visually confirmed after application, and the remaining washing can also be confirmed by the coloring effect.
The external preparation for skin used in the present invention contains an α-hydroxy acid and is preferably used for chemical peeling. Therefore, it is removed after a lapse of a certain time after application to the skin. However, when the base is transparent, it is difficult to recognize unwashed-off or unwiped-off, causing irritation.
As (d) titanium oxide used for this invention, what is normally used in the cosmetics field | area can be used.
成分(d)を配合する場合、その配合量は本発明の皮膚外用剤全量中に0.1〜3.0質量%であるが、好ましくは0.5〜2.0質量%であり、さらに好ましくは1.0〜1.5質量%である。0.1質量%未満では、十分な着色効果をもたらすことができず、また3.0質量%を越えても着色効果はあがらない。 When the component (d) is blended, the blending amount is 0.1 to 3.0% by weight in the total amount of the external preparation for skin of the present invention, preferably 0.5 to 2.0% by weight, Preferably it is 1.0-1.5 mass%. If the amount is less than 0.1% by mass, a sufficient coloring effect cannot be obtained, and if it exceeds 3.0% by mass, the coloring effect does not increase.
本発明の皮膚外用剤のpHは2.0〜5.0であるが、皮膚への刺激性および効果の観点から、好ましくはpH3.0〜5.0、より好ましくはpH3.5〜4.5である。 Although the pH of the external preparation for skin of the present invention is 2.0 to 5.0, from the viewpoint of irritation to skin and effects, it is preferably pH 3.0 to 5.0, more preferably pH 3.5 to 4. 5.
また、本発明の皮膚外用剤の粘度は10000〜30000mPa・s/30℃であることが好ましく、より好ましくは20000〜25000mPa・s/30℃である。この範囲で、垂れ落ちのなさ、塗布しやすさなどの使用性が最適のものが得られる。 Moreover, it is preferable that the viscosity of the skin external preparation of this invention is 10000-30000 mPa * s / 30 degreeC, More preferably, it is 20000-25000 mPa * s / 30 degreeC. Within this range, the optimum usability such as no dripping and ease of application can be obtained.
さらに配合する中和剤としては、特に限定はされないが、苛性カリ、苛性ソーダ、クエン酸ナトリウム、炭酸ナトリウム、炭酸水素ナトリウム、アンモニア、トリエタノールアミン、L−アルギニン、L−リジン等が挙げられる。特に、クエン酸ナトリウム、苛性ソーダが好ましい。本発明の皮膚外用剤中に、これらの中和剤を単独で配合しても、または必要に応じて2種以上を組み合わせて配合してもよい。 Further, the neutralizing agent to be blended is not particularly limited, and examples thereof include caustic potash, caustic soda, sodium citrate, sodium carbonate, sodium hydrogen carbonate, ammonia, triethanolamine, L-arginine, and L-lysine. In particular, sodium citrate and caustic soda are preferable. In the skin external preparation of this invention, these neutralizing agents may be mix | blended independently or may be mix | blended in combination of 2 or more type as needed.
本発明の皮膚外用剤における中和剤の配合量は、好ましくは、外用剤全量に対して0.1〜2.0質量%であり、より好ましくは0.5〜1.5質量%である。 The blending amount of the neutralizing agent in the external preparation for skin of the present invention is preferably 0.1 to 2.0% by mass, more preferably 0.5 to 1.5% by mass with respect to the total amount of external preparation. .
本発明の皮膚外用剤の製造方法としては、特に限定されないが、例えば、精製水にすべての成分を溶解し、ろ過して目的の皮膚外用剤を得る方法が挙げられる。 Although it does not specifically limit as a manufacturing method of the skin external preparation of this invention, For example, the method of melt | dissolving all the components in purified water and filtering and obtaining the target skin external preparation is mentioned.
本発明の皮膚外用剤は、皮膚に塗布後、一定時間放置したのちに除去するタイプの外用剤であり、ケミカルピーリング用の外用剤として用いることが好ましい。通常は、その使用方法として、皮膚に塗布後一定時間放置してから洗い流す方法がとられるが、濡れたコットンあるいはタオルで拭取ることもできる。 The external preparation for skin of the present invention is a type of external preparation that is removed after standing for a certain period of time after being applied to the skin, and is preferably used as an external preparation for chemical peeling. Usually, as a method of use, a method of leaving it for a certain period of time after being applied to the skin and washing it off is taken, but it can also be wiped off with wet cotton or towel.
特に本発明の皮膚外用剤を用いてケミカルピーリングを行う場合は、例えば次のような適用方法が挙げられる。
本発明の皮膚外用剤を皮膚に塗布した後、所定時間放置後、洗い流す操作を2〜3日、好ましくは2日おいて繰り返す。塗布後の放置時間は、3〜5分程度であることが好ましい。繰り返しの回数は、1回以上であり、好ましくは3回以上、例えば3〜7回繰り返して行う。繰り返し回数が3回の場合、適用回数は計4回となる。
In particular, when chemical peeling is performed using the external preparation for skin of the present invention, for example, the following application method can be mentioned.
After applying the external preparation for skin of the present invention to the skin, it is allowed to stand for a predetermined time, and then the washing operation is repeated for 2 to 3 days, preferably 2 days. The standing time after application is preferably about 3 to 5 minutes. The number of repetitions is one or more times, preferably three or more times, for example, 3 to 7 times. When the number of repetitions is 3, the total number of applications is 4.
本発明において、「皮膚外用剤」は、外皮に適用するものであれば特に限定されず、化粧料、医薬品、医薬部外品等を含む。また、その剤型は増粘された剤型であればよく、任意の剤型を含む。また、シート状基剤に担持されたものも含む。 In the present invention, the “skin external preparation” is not particularly limited as long as it is applied to the outer skin, and includes cosmetics, pharmaceuticals, quasi drugs and the like. Moreover, the dosage form should just be a thickened dosage form, and includes arbitrary dosage forms. Moreover, what was carry | supported by the sheet-like base is also included.
本発明の皮膚外用剤は、上記した必須構成成分の他に、通常化粧品や医薬品等の皮膚外用剤に用いられる他の任意の成分を必要に応じて適宜配合し、目的とする剤形に応じて常法により製造することが出来る。例えば、上記必須配合成分と、下記成分の1種または2種以上とを配合して本発明の皮膚外用剤を調製できる。 The external preparation for skin of the present invention contains, in addition to the above-described essential constituents, other optional components that are usually used in external preparations for skin, such as cosmetics and pharmaceuticals, as appropriate, depending on the intended dosage form. Can be produced by conventional methods. For example, the external preparation for skin of the present invention can be prepared by blending the above essential blending components and one or more of the following components.
紫外線吸収剤としては、例えば、パラアミノ安息香酸(以下PABAと略す)、PABAモノグリセリンエステル、N,N-ジプロポキシPABAエチルエステル、N,N-ジエトキシPABAエチルエステル、N,N-ジメチルPABAエチルエステル、N,N-ジメチルPABAブチルエステル、N,N-ジメチルPABAメチルエステル等の安息香酸系紫外線吸収剤、ホモメンチル-N-アセチルアントラニレート等のアントラニル酸系紫外線吸収剤、アミルサリシレート、メンチルサリシレート、ホモメンチルサリシレート、オクチルサリシレート、フェニルサリシレート、ベンジルサリシレート、p-イソプロパノールフェニルサリシレート等のサリチル酸系紫外線吸収剤、オクチルシンナメート、エチル-4-イソプロピルシンナメート、メチル-2,5-ジイソプロピルシンナメート、エチル-2,4-ジイソプロピルシンナメート、メチル-2,4-ジイソプロピルシンナメート、プロピル-p-メトキシシンナメート、イソプロピル-p-メトキシシンナメート、イソアミル-p-メトキシシンナメート、オクチル-p-メトキシシンナメート(2- エチルヘキシル-p-メトキシシンナメート)、2-エトキシエチル-p-メトキシシンナメート、シクロヘキシル-p-メトキシシンナメート、エチル-α-シアノ−β-フェニルシンナメート、2-エチルヘキシル-α-シアノ-β-フェニルシンナメート、グリセリルモノ-2-エチルヘキサノイル-ジパラメトキシシンナメート、トリメトキシ桂皮酸メチルビス(トリメチルシロキサン)シリルイソペンチル等の桂皮酸系紫外線吸収剤、3-(4'-メチルベンジリデン)-d,1-カンファー、3-ベンジリデン-d,1-カンファー、ウロカニン酸、ウロカニン酸エチルエステル、2-フェニル-5-メチルベンゾキサゾール、2,2'-ヒドロキシ-5-メチルフェニルベンゾトリアゾール、2-(2'-ヒドロキシ-5'-t-オクチルフェニル)ベンゾトリアゾール、2-(2'-ヒドロキシ-5'-メチルフェニルベンゾトリアゾール、ジベンザラジン、ジアニソイルメタン、4-メトキシ-4'-t-ブチルジベンゾイルメタン、5-(3,3-ジメチル-2-ノルボルニリデン)-3-ペンタン-2-オン、ジモルホリノピリダジノン等が挙げられ、任意の1種または2種以上を用いることができる。 Examples of the ultraviolet absorber include paraaminobenzoic acid (hereinafter abbreviated as PABA), PABA monoglycerin ester, N, N-dipropoxy PABA ethyl ester, N, N-diethoxy PABA ethyl ester, N, N-dimethyl PABA ethyl ester, Benzoic acid UV absorbers such as N, N-dimethyl PABA butyl ester and N, N-dimethyl PABA methyl ester, anthranilic acid UV absorbers such as homomenthyl-N-acetylanthranilate, amyl salicylate, menthyl salicylate, homo Salicylic acid UV absorbers such as menthyl salicylate, octyl salicylate, phenyl salicylate, benzyl salicylate, p-isopropanol phenyl salicylate, octyl cinnamate, ethyl-4-isopropylcinnamate, methyl-2,5-diisopropylcinnamate, ethyl-2 , 4-Diisopropylcinna , Methyl-2,4-diisopropylcinnamate, propyl-p-methoxycinnamate, isopropyl-p-methoxycinnamate, isoamyl-p-methoxycinnamate, octyl-p-methoxycinnamate (2-ethylhexyl-p -Methoxycinnamate), 2-ethoxyethyl-p-methoxycinnamate, cyclohexyl-p-methoxycinnamate, ethyl-α-cyano-β-phenylcinnamate, 2-ethylhexyl-α-cyano-β-phenylcinnamate Cinnamate UV absorbers such as glyceryl mono-2-ethylhexanoyl-diparamethoxycinnamate, methyl bis (trimethylsiloxane) silylisopentyl trimethoxycinnamate, 3- (4′-methylbenzylidene) -d, 1- Camphor, 3-benzylidene-d, 1-camphor, urocanic acid, urocanic acid ethyl ester, 2-phenyl-5-methyl Rubenzoxazole, 2,2'-hydroxy-5-methylphenylbenzotriazole, 2- (2'-hydroxy-5'-t-octylphenyl) benzotriazole, 2- (2'-hydroxy-5'-methyl) Phenylbenzotriazole, dibenzalazine, dianisoylmethane, 4-methoxy-4'-t-butyldibenzoylmethane, 5- (3,3-dimethyl-2-norbornylidene) -3-pentan-2-one, dimorpholinopyrida Dinone etc. are mentioned, Arbitrary 1 type, or 2 or more types can be used.
紫外線散乱剤としては、(d)成分である酸化チタン、微粒子酸化チタンや、酸化亜鉛、微粒子酸化亜鉛、酸化鉄、微粒子酸化鉄、酸化セリウムなどの粉末が挙げられる。 Examples of the ultraviolet scattering agent include powders such as component (d) titanium oxide, fine particle titanium oxide, zinc oxide, fine particle zinc oxide, iron oxide, fine particle iron oxide, and cerium oxide.
これら紫外線散乱剤は、通常、針状、紡錘状、球状、粒状の粉末が使用される。また、粒子径が0.1μm以下の微粒子粉末が好ましい。 As these ultraviolet scattering agents, needle-like, spindle-like, spherical and granular powders are usually used. A fine particle powder having a particle size of 0.1 μm or less is preferred.
メチルハイドロジェンポリシロキサンやシランカップリング剤などのシリコーン処理;金属石鹸処理;パーフルオロアルキルリン酸ジエタノールアミン塩やパーフルオロアルキルシラン等のフッ素処理、デキストリン脂肪酸エステル処理等により、疎水化処理した紫外線散乱剤も好ましい。 Silicone treatment such as methyl hydrogen polysiloxane and silane coupling agent; metal soap treatment; UV scattering agent that has been hydrophobized by fluorine treatment such as perfluoroalkyl phosphate diethanolamine salt and perfluoroalkyl silane, dextrin fatty acid ester treatment, etc. Is also preferable.
液体油脂としては、例えば、アボガド油、ツバキ油、タートル油、マカデミアナッツ油、トウモロコシ油、ミンク油、オリーブ油、ナタネ油、卵黄油、ゴマ油、パーシック油、小麦胚芽油、サザンカ油、ヒマシ油、アマニ油、サフラワー油、綿実油、エノ油、大豆油、落花生油、茶実油、カヤ油、コメヌカ油、シナギリ油、日本キリ油、ホホバ油、胚芽油、トリグリセリン等が挙げられる。 Examples of liquid oils include avocado oil, camellia oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, southern castor oil, castor oil, linseed oil , Safflower oil, cottonseed oil, eno oil, soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, cinnagiri oil, Japanese kiri oil, jojoba oil, germ oil, triglycerin and the like.
固体油脂としては、例えば、カカオ脂、ヤシ油、馬脂、硬化ヤシ油、パーム油、牛脂、羊脂、硬化牛脂、パーム核油、豚脂、牛骨脂、モクロウ核油、硬化油、牛脚脂、モクロウ、硬化ヒマシ油等が挙げられる。 Examples of the solid fat include cacao butter, palm oil, horse fat, hydrogenated palm oil, palm oil, beef tallow, sheep fat, hydrogenated beef tallow, palm kernel oil, pork fat, beef bone fat, owl kernel oil, hydrogenated oil, cattle Leg fats, moles, hydrogenated castor oil and the like.
ロウ類としては、例えば、ミツロウ、カンデリラロウ、綿ロウ、カルナウバロウ、ベイベリーロウ、イボタロウ、鯨ロウ、モンタンロウ、ヌカロウ、ラノリン、カポックロウ、酢酸ラノリン、液状ラノリン、サトウキビロウ、ラノリン脂肪酸イソプロピル、ラウリン酸ヘキシル、還元ラノリン、ジョジョバロウ、硬質ラノリン、セラックロウ、POEラノリンアルコールエーテル、POEラノリンアルコールアセテート、POEコレステロールエーテル、ラノリン脂肪酸ポリエチレングリコール、POE水素添加ラノリンアルコールエーテル等が挙げられる。 Examples of waxes include beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, ibota wax, whale wax, montan wax, nuka wax, lanolin, kapok wax, lanolin acetate, liquid lanolin, sugar cane wax, lanolin fatty acid isopropyl, hexyl laurate, and reduced lanolin. , Jojoballow, hard lanolin, shellac wax, POE lanolin alcohol ether, POE lanolin alcohol acetate, POE cholesterol ether, lanolin fatty acid polyethylene glycol, POE hydrogenated lanolin alcohol ether, and the like.
炭化水素油としては、例えば、流動パラフィン、オゾケライト、スクワラン、プリスタン、パラフィン、セレシン、スクワレン、ワセリン、マイクロクリスタリンワックス、ポリエチレンワックス、フィッシャートロプッシュワックス等が挙げられる。 Examples of the hydrocarbon oil include liquid paraffin, ozokerite, squalane, pristane, paraffin, ceresin, squalene, petrolatum, microcrystalline wax, polyethylene wax, and Fischer-Tropsch wax.
高級脂肪酸としては、例えば、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘニン酸、オレイン酸、ウンデシレン酸、トール酸、リノール酸、リノレイン酸、エイコサペンタエン酸(EPA)、ドコサヘキサエン酸(DHA)等が挙げられる。 Examples of higher fatty acids include lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, undecylenic acid, toluic acid, linoleic acid, linolenic acid, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and the like. Is mentioned.
高級アルコールとしては、例えば、直鎖アルコール(例えば、ラウリルアルコール、セチルアルコール、ステアリルアルコール、ベヘニルアルコール、ミリスチルアルコール、オレイルアルコール、セトステアリルアルコール等);分枝鎖アルコール(例えば、モノステアリルグリセリンエーテル(バチルアルコール)、2-デシルテトラデシノール、ラノリンアルコール、コレステロール、フィトステロール、ヘキシルドデカノール、オクチルドデカノール等)等が挙げられる。 Examples of higher alcohols include linear alcohols (eg, lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, cetostearyl alcohol); branched chain alcohols (eg, monostearyl glycerin ether (batyl alcohol) ), 2-decyltetradecinol, lanolin alcohol, cholesterol, phytosterol, hexyldodecanol, octyldodecanol and the like.
合成エステル油としては、ミリスチン酸イソプロピル、オクタン酸セチル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、ステアリン酸ブチル、ラウリン酸ヘキシル、ミリスチン酸ミリスチル、オレイン酸デシル、ジメチルオクタン酸ヘキシルデシル、乳酸セチル、乳酸ミリスチル、酢酸ラノリン、ステアリン酸イソセチル、イソステアリン酸イソセチル、12-ヒドロキシステアリン酸コレステリル、ジ-2-エチルヘキサン酸エチレングリコール、ジペンタエリスリトール脂肪酸エステル、モノイソステアリン酸N-アルキルグリコール、ジカプリン酸ネオペンチルグリコール、リンゴ酸ジイソステアリル、ジ-2-ヘプチルウンデカン酸グリセリン、トリ-2-エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ-2-エチルヘキサン酸ペンタエリスリトール、トリ-2-エチルヘキサン酸グリセリン、トリオクタン酸グリセリン、トリイソパルミチン酸グリセリン、トリイソステアリン酸トリメチロールプロパン、セチル2-エチルヘキサノエート、2-エチルヘキシルパルミテート、トリミリスチン酸グリセリン、トリ-2-ヘプチルウンデカン酸グリセライド、ヒマシ油脂肪酸メチルエステル、オレイン酸オレイル、アセトグリセライド、パルミチン酸2-ヘプチルウンデシル、アジピン酸ジイソブチル、N-ラウロイル-L-グルタミン酸-2-オクチルドデシルエステル、アジピン酸ジ-2-ヘプチルウンデシル、エチルラウレート、セバシン酸ジ−2-エチルヘキシル、ミリスチン酸2-ヘキシルデシル、パルミチン酸2-ヘキシルデシル、アジピン酸2-ヘキシルデシル、コハク酸2-エチルヘキシル、クエン酸トリエチル、ポリオキシエチレン・ポリオキシプロピレンランダム重合体メチルエーテル等が挙げられる。 Synthetic ester oils include isopropyl myristate, cetyl octanoate, octyldodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, hexyl decyl dimethyloctanoate, cetyl lactate, myristyl lactate Lanolin acetate, isocetyl stearate, isocetyl isostearate, cholesteryl 12-hydroxystearate, ethylene glycol di-2-ethylhexanoate, dipentaerythritol fatty acid ester, monoisostearic acid N-alkyl glycol, dicapric acid neopentyl glycol, apple Acid diisostearyl, di-2-heptylundecanoic acid glycerin, tri-2-ethylhexanoic acid trimethylolpropane, triisostearic acid trimethylo Propane, tetra-2-ethylhexanoate pentaerythritol, glycerol tri-2-ethylhexanoate, glycerol trioctanoate, glycerol triisopalmitate, trimethylolpropane triisostearate, cetyl 2-ethylhexanoate, 2-ethylhexyl palmi Tate, glyceryl trimyristate, glyceride tri-2-heptylundecanoate, castor oil fatty acid methyl ester, oleyl oleate, acetoglyceride, 2-heptylundecyl palmitate, diisobutyl adipate, N-lauroyl-L-glutamic acid-2 -Octyldodecyl ester, di-2-heptylundecyl adipate, ethyl laurate, di-2-ethylhexyl sebacate, 2-hexyldecyl myristate, 2-hexyldecyl palmitate, 2-hexyldecyl adipate Le, 2-ethylhexyl succinate, triethyl citrate, polyoxyethylene-polyoxypropylene random polymer methyl ether.
シリコーン油としては、例えば、鎖状ポリシロキサン(例えば、ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等);環状ポリシロキサン(例えば、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサシロキサン等)、3次元網目構造を形成しているシリコーン樹脂、シリコーンゴム、各種変性ポリシロキサン(アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等)等が挙げられる。 Examples of the silicone oil include linear polysiloxanes (for example, dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxane, etc.); cyclic polysiloxanes (for example, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexyl). And silicone resins that form a three-dimensional network structure, various modified polysiloxanes (amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, fluorine-modified polysiloxane, etc.) It is done.
その他には、エタノール等の低級アルコール;ブチルヒドロキシトルエン,トコフェロール,フィチン等の酸化防止剤;安息香酸,ソルビン酸,パラオキシ安息香酸アルキルエステル,ヘキサクロロフェン等の抗菌剤;アシルサルコシン酸(例えばラウロイルサルコシンナトリウム)、グルタチオン等の有機酸;ビタミンAおよびその誘導体、ビタミンB6塩酸塩,ビタミンB6トリパルミテート,ビタミンB6ジオクタノエート,ビタミンB2およびその誘導体,ビタミンB12,ビタミンB15およびその誘導体等のビタミンB類、アスコルビン酸,アスコルビン酸硫酸エステル(塩),アスコルビン酸リン酸エステル(塩),アスコルビン酸ジパルミテート等のビタミンC類、α−トコフェロール,β−トコフェロール,δ−トコフェロール,酢酸トコフェロール等のビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチン等のビタミン類;ニコチン酸アミド、ニコチン酸ベンジル、γ−オリザノール、アラントイン、グリチルリチン酸(塩)、グリチルレチン酸およびその誘導体、ヒノキチオール、ビサボロール、チモール、イノシトール、サイコサポニン、ニンジンサポニン、ヘチマサポニン、ムクロジサポニン等のサポニン類、パントテニルエチルエーテル、エチニルエストラジオール、トラネキサム酸、アルブチン、セファランチン、プラセンタエキス等の各種薬剤、ギシギシ、クララ、コウホネ、オレンジ、セージ、ノコギリソウ、ゼニアオイ、センブリ、タイム、トウキ、トウヒ、バーチ、スギナ、ヘチマ、マロニエ、ユキノシタ、アルニカ、ユリ、ヨモギ、シャクヤク、アロエ、クチナシ、サワラ、セイヨウサンザシエキス、セイヨウオトギリソウエキス、アイリス・インエキス、アセンヤクエキス、イチョウ葉エキス、イブキジャコウエキス、ウイキョウエキス、ウーロン茶エキス、ウオーターリリーエキス、エイジツエキス、エンメイソウエキス、オウゴンエキス、オウバクエキス、オドリコソウエキス、カンゾウエキス、クチナシエキス、紅茶エキス、セイカリュウエキス、トルメンチラエキス、バラエキス、ヘチマエキス、ペパーミントエキス、ローズマリーエキス、ローヤルゼリーエキス等の植物の抽出物、色素、モノラウリン酸ソルビタン、モノパルミチン酸ソルビタン、セスキオレイン酸ソルビタン、トリオレイン酸ソルビタン、モノラウリン酸ポリオキシエチレンソルビタン、モノステアリン酸ポリオキセチレンソルビタン、ポリエチレングリコールモノオレート、ポリオキシエチレンアルキルエーテル、ポリグリコールジエーテル、ラウロイルジエタノールアマイド、脂肪酸イソプロパノールアマイド、マルチトールヒドロキシ脂肪酸エーテル、アルキル化多糖、アルキルグルコシド、シュガーエステル等の非イオン性活性剤、ステアリルトリメチルアンモニウムクロライド、塩化ベンザルコニウム、ラウリルアミンオキサイド等のカチオン性界面活性剤、パルミチン酸ナトリウム、ラウリン酸ナトリウム、ラウリル酸ナトリウム、ラウリル硫酸カリウム、アルキル硫酸トリエタノールアミンエーテル、ロート油、リニアドデシルベンゼン硫酸、ポリオキシエチレン硬化ヒマシ油マレイン酸、アシルメチルタウリン等のアニオン性界面活性剤、両性界面活性剤、δ−トコフェロール、ブチルヒドロキシトルエン等の酸化防止剤、フェノキシエタノール、パラベン等の防腐剤が挙げられる。 Others include lower alcohols such as ethanol; antioxidants such as butylhydroxytoluene, tocopherol, and phytin; antibacterial agents such as benzoic acid, sorbic acid, alkyl alkyl parabenzoate, and hexachlorophene; acyl sarcosine acid (eg, lauroyl sarcosine sodium) ), Organic acids such as glutathione; vitamin B and its derivatives, vitamin B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 dioctanoate, vitamin B2 and its derivatives, vitamin B such as vitamin B12, vitamin B15 and its derivatives, ascorbine Vitamin C such as acid, ascorbic acid sulfate (salt), ascorbic acid phosphate (salt), ascorbic acid dipalmitate, α-tocopherol, β-tocopherol, δ-tocophero And vitamins such as tocopherol acetate, vitamin D, vitamin H, pantothenic acid, pantethine; nicotinamide, benzyl nicotinate, γ-oryzanol, allantoin, glycyrrhizic acid (salt), glycyrrhetinic acid and its Derivatives, hinokitiol, bisabolol, thymol, inositol, saikosaponin, carrot saponin, hechisaponin, muclodisaponin and other saponins, pantothenyl ethyl ether, ethinyl estradiol, tranexamic acid, arbutin, cephalanthin, placenta extract and other various drugs, Clara, corn, orange, sage, yarrow, mallow, assembly, thyme, spruce, spruce, birch, horsetail, loofah, maronier, yukinoshita, arnica, lily, Artemisia, Peonies, Aloe, Gardenia, Sawara, Hawthorn extract, Hypericum perforatum extract, Iris in extract, Acacia extract, Ginkgo biloba extract, Eustoma biloba extract, Fennel extract, Oolong tea extract, Water lily extract, Ages extract, Enmeisou Extracts, plant extracts such as extract, green grass extract, grasshopper extract, licorice extract, licorice extract, gardenia extract, black tea extract, sesame extract, tormentilla extract, rose extract, loofah extract, peppermint extract, rosemary extract, royal jelly extract, Dye, sorbitan monolaurate, sorbitan monopalmitate, sorbitan sesquioleate, sorbitan trioleate, polyoxyethylene sorbate monolaurate , Polysoxyethylene sorbitan monostearate, polyethylene glycol monooleate, polyoxyethylene alkyl ether, polyglycol diether, lauroyl diethanol amide, fatty acid isopropanol amide, maltitol hydroxy fatty acid ether, alkylated polysaccharide, alkyl glucoside, sugar ester, etc. Nonionic activators, stearyl trimethyl ammonium chloride, cationic surfactants such as benzalkonium chloride, laurylamine oxide, sodium palmitate, sodium laurate, sodium laurate, potassium lauryl sulfate, triethanolamine ether of alkyl sulfate , Funnel oil, linear dodecylbenzene sulfate, polyoxyethylene hydrogenated castor oil maleic acid, acylmethyl Anionic surfactants such as phosphorus, amphoteric surfactants, .delta.-tocopherol, antioxidant such as butylhydroxytoluene, phenoxyethanol, preservatives such as paraben and the like.
さらに、本発明の皮膚外用剤は、α−ヒドロキシ酸の他に、例えばN,N,N−トリメチルグリシン(TMG)、L−セリン、マロン酸、またはコハク酸のような他の任意の角質剥離剤をさらに含んでいてもよい。そのような角質剥離剤をさらに配合することによって、より高い美肌効果をもたらすことができる。 Furthermore, the external preparation for skin of the present invention is not limited to α-hydroxy acid, but any other exfoliated keratin exfoliation such as N, N, N-trimethylglycine (TMG), L-serine, malonic acid, or succinic acid. An agent may further be included. By further blending such a keratin remover, a higher skin beautifying effect can be brought about.
以下、実施例を挙げて本発明をさらに詳しく説明する。本発明はこれらの実施例により限定されるものではない。配合量については特に断りのない限り質量%を示す。
実施例に先立ち、本発明で用いた評価方法を説明する。また、本実施例で用いた(a)成分の合成方法についても記載する。
Hereinafter, the present invention will be described in more detail with reference to examples. The present invention is not limited to these examples. Unless otherwise specified, the blending amount indicates mass%.
Prior to the examples, the evaluation method used in the present invention will be described. Moreover, it describes also about the synthesis | combining method of (a) component used in the present Example.
(1)効果の評価方法
20名の専門パネルによって試料を使用し、次のような実使用試験を行った。試験項目は、指取れやすさ、塗布しやすさ、洗い流している時のぬめり、洗い流しやすさである。それぞれの評価項目について、下記の評価点基準に基づいて評価した。次いで、各人がつけた評価点を合計し、下記評価基準に基づいて評価した。
(1) Evaluation method of effect The sample was used by 20 professional panels, and the following actual use tests were conducted. The test items are ease of finger removal, ease of application, slimming during washing, and ease of washing. Each evaluation item was evaluated based on the following evaluation point criteria. Subsequently, the evaluation points given by each person were totaled and evaluated based on the following evaluation criteria.
(実使用試験方法)
調製したケミカルピーリング用皮膚外用剤を専門パネルにより1群10名で2日おきに合計4回適用してもらった。適用方法は、夜、洗顔後に、外用剤を指にとり、目のまわり、口のまわり、鼻孔、生え際を避け、均一に広げる。5分間放置し、流水で約1分間を目安に、強くこすらないよう水かぬるま湯で十分に洗い流す。
ケミカルピーリング用剤適用期間中の刺激のなさの評価、ならびに肌状態(つるつる感、すべすべ感)の評価を下記の評価点基準に基づいて評価した。次いで、各人がつけた評価点を合計し、下記評価基準に基づいて評価した。
(Actual test method)
The prepared chemical exfoliating skin external preparation was applied to a group of 10 people per group for a total of 4 times every 2 days. The method of application is to apply the external preparation to the fingers after washing the face at night, and spread it evenly around the eyes, around the mouth, nostrils and hairline. Leave it for 5 minutes, and rinse it with running water or lukewarm water so that it does not rub hard.
Evaluation of the absence of irritation during the application period of the chemical peeling agent and evaluation of the skin condition (smooth feeling, smooth feeling) were evaluated based on the following evaluation criteria. Subsequently, the evaluation points given by each person were totaled and evaluated based on the following evaluation criteria.
(評価点基準)
5点:非常に優れている。
4点:優れている。
3点:普通。
2点:劣る。
1点:非常に劣る。
(Evaluation criteria)
5 points: Excellent.
4 points: Excellent.
3 points: Normal.
2 points: Inferior.
1 point: Very inferior.
(評価基準)
◎:平均点が4以上〜5である。
○:平均点が3以上〜4未満である。
△:平均点が2以上〜3未満である。
×:平均点が1以上〜2未満である。
(Evaluation criteria)
A: The average score is 4 or more and 5.
A: The average score is 3 or more and less than 4.
Δ: The average score is 2 or more and less than 3.
X: The average point is 1 or more and less than 2.
(2)架橋型N,N−ジメチルアクリルアミド−2−アクリルアミド−2−メチルプロパンスルホン酸ナトリウム共重合体の合成
ジメチルアクリルアミド(興人社製)を35gと2-アクリルアミド2-メチルプロパンスルホン酸(Sigma社製)17.5gおよびメチレンビスアクリルアミド7mgを260gのイオン交換水に溶解し水酸化ナトリウムでpH=7.0に調節する。還流装置を備えた1000ml三つ口フラスコに、n-ヘキサン260gとポリオキシエチレン(3)オレイルエーテル(エマレックス503、日本エマルション製)8.7gおよびエポリオキシエチレン(6)オレイルエーテル(エマレックス506、日本エマルション製)17.6gを入れ混合溶解し、N2置換する。この三つ口フラスコにモノマー水溶液を添加してN2雰囲気下で攪拌しながらオイルバスで65℃〜70℃に加熱する。系の温度が65℃ 〜 70℃ に達したところで系が半透明なマイクロエマルション状態になっていることを確認した後、過硫酸アンモニウム2gを重合系に添加し重合を開始する。重合系を65〜 70℃ に3時間攪拌しながら維持することでミクロゲルが生成する。重合終了後ミクロゲル懸濁液にアセトンを加えてミクロゲルを沈殿させ、引き続きアセトンで3回洗浄し、残存モノマーおよび界面活性剤を除去する。沈殿物は濾過後減圧乾燥し、白色粉末状のミクロゲル乾燥物を得る。
(2) Synthesis of crosslinked N, N-dimethylacrylamide-2-acrylamido-2-methylpropanesulfonic acid sodium copolymer 35 g of dimethylacrylamide (manufactured by Kojin Co., Ltd.) and 2-acrylamido-2-methylpropanesulfonic acid (Sigma) 17.5 g) and 7 mg of methylenebisacrylamide are dissolved in 260 g of ion-exchanged water and adjusted to pH = 7.0 with sodium hydroxide. In a 1000 ml three-necked flask equipped with a reflux apparatus, 260 g of n-hexane, polyoxyethylene (3) oleyl ether (Emalex 503, manufactured by Nippon Emulsion) 8.7 g and epolyoxyethylene (6) oleyl ether (Emalex 506) , Made in Japan Emulsion) 17.6g is mixed and dissolved, and N 2 is substituted. An aqueous monomer solution is added to the three-necked flask and heated to 65 ° C. to 70 ° C. in an oil bath while stirring under an N 2 atmosphere. After confirming that the system is in a translucent microemulsion state when the temperature of the system reaches 65 ° C. to 70 ° C., 2 g of ammonium persulfate is added to the polymerization system to start the polymerization. A microgel is formed by maintaining the polymerization system at 65-70 ° C. with stirring for 3 hours. After the polymerization is completed, acetone is added to the microgel suspension to precipitate the microgel, followed by washing with acetone three times to remove residual monomer and surfactant. The precipitate is filtered and dried under reduced pressure to obtain a dried white powdered microgel.
実施例1〜10、比較例1〜3
下記表1、表2に示した各処方成分よりなるケミカルピーリング用外用剤を下記の方法(1)〜(3)で調製した。得られたケミカルピーリング用外用剤について、上記の基準で、指取れやすさ、塗布しやすさ、洗い流している時のぬめり、洗い流しやすさを評価した。その結果を併せて表1、表2に示す。
Examples 1-10, Comparative Examples 1-3
External preparations for chemical peeling comprising the respective formulation components shown in Tables 1 and 2 below were prepared by the following methods (1) to (3). The obtained external agent for chemical peeling was evaluated on the above criteria for ease of finger removal, ease of application, slimming during washing, and ease of washing. The results are also shown in Tables 1 and 2.
(1)実施例1〜10の外用剤の製造方法
イオン交換水に架橋型N,N−ジメチルアクリルアミド−2−アクリルアミド−2−メチルプロパンスルホン酸ナトリウム共重合体を溶解した後、グリコール酸を添加して溶解し、水酸化ナトリウムを添加して中和した。予め一部の精製水に加熱溶解した(PEG−240/デシルテトラデセス−20/HDI)コポリマーを混合し、その後、残りの成分を溶解し、ろ過して外用剤を得た。
(1) Method for producing external preparations of Examples 1 to 10 After dissolving a crosslinked N, N-dimethylacrylamide-2-acrylamido-2-methylpropanesulfonate sodium copolymer in ion-exchanged water, glycolic acid is added. And dissolved, and neutralized by adding sodium hydroxide. A copolymer (PEG-240 / decyltetradeceth-20 / HDI) dissolved in advance in a part of purified water was mixed, and then the remaining components were dissolved and filtered to obtain an external preparation.
(2)比較例1、3の外用剤の製造方法
精製水に架橋型N,N−ジメチルアクリルアミド−2−アクリルアミド−2−メチルプロパンスルホン酸ナトリウム共重合体を溶解した後、グリコール酸を添加して溶解し、水酸化ナトリウムを添加して中和した。その後、残りの成分を溶解し、ろ過して外用剤を得た。
(2) Method for producing external preparation of Comparative Examples 1 and 3 After dissolving the crosslinked N, N-dimethylacrylamide-2-acrylamido-2-methylpropanesulfonate sodium copolymer in purified water, glycolic acid was added. And then neutralized by adding sodium hydroxide. Thereafter, the remaining components were dissolved and filtered to obtain an external preparation.
(3)比較例2の外用剤の製造方法
精製水にグリコール酸を添加して溶解し、水酸化ナトリウムを添加して中和した。予め一部の精製水に加熱溶解した(PEG−240/デシルテトラデセス−20/HDI)コポリマーを混合し、その後、残りの成分を溶解し、ろ過して外用剤を得た。
(3) Manufacturing method of external preparation of Comparative Example 2 Glycolic acid was added to and dissolved in purified water, and sodium hydroxide was added for neutralization. A copolymer (PEG-240 / decyltetradeceth-20 / HDI) dissolved in advance in a part of purified water was mixed, and then the remaining components were dissolved and filtered to obtain an external preparation.
※1:アデカノールGT−700(ADEKA社製) * 1: Adecanol GT-700 (manufactured by ADEKA)
本発明のグリコール酸と架橋型N,N−ジメチルアクリルアミド−2−アクリルアミド−2−メチルプロパンスルホン酸ナトリウム共重合体および(PEG−240/デシルテトラデセス−20/HDI )コポリマーとを含有する皮膚外用剤(実施例1〜5)は、指取れもよくしかも洗い流しやすさに非常に優れていた。
一方、グリコール酸と架橋型N,N−ジメチルアクリルアミド−2−アクリルアミド−2−メチルプロパンスルホン酸ナトリウム共重合体のみを含有する皮膚外用剤(比較例1)では、指取れはいいが、洗い流しやすさが非常に悪かった。また、グリコール酸と(PEG−240/デシルテトラデセス−20/HDI)コポリマーのみを含有する皮膚外用剤(比較例2)においては、洗い流しやすさはいいが、指取れは非常に悪かった。
Skin containing glycolic acid of the present invention and crosslinked N, N-dimethylacrylamide-2-acrylamido-2-methylpropanesulfonic acid sodium copolymer and (PEG-240 / decyltetradeceth-20 / HDI) copolymer The external preparations (Examples 1 to 5) were excellent in finger picking and ease of washing.
On the other hand, the external preparation for skin (Comparative Example 1) containing only glycolic acid and a cross-linked sodium N, N-dimethylacrylamide-2-acrylamido-2-methylpropanesulfonate is easy to wash out, although it is easy to finger. It was very bad. In addition, in the external preparation for skin containing only glycolic acid and (PEG-240 / decyltetradeceth-20 / HDI) copolymer (Comparative Example 2), although it was easy to wash off, finger picking was very bad.
実施例11(化粧料キット)
日中用クリーム、夜用クリーム、エッセンス(保湿液)、マスク、上記実施例4記載の皮膚外用剤よりなる化粧料キットとした。日中用クリーム、夜用クリームおよびエッセンスは、市販され、通常一般的に用いられているものである。
この化粧料キットは、朝の手入れ用としてエッセンスと日中用クリーム(朝操作1)、夜の手入れ用としてエッセンスと夜用クリーム(夜操作1)、あるいは実施例4記載の皮膚外用剤とマスクと夜用クリーム(夜操作2)が用いられる。
使用方法としては、朝、夜共に洗顔後に適用する。朝の手入れは、朝操作1を毎日行う。夜の手入れは、夜操作2−夜操作1−夜操作1−夜操作2−夜操作1−夜操作1−夜操作2−…のように、2日おきに夜操作2をいれて行い、夜操作2が4回程度行われるようにする。
また夜操作2の使用方法は、次のとおりである。
(1)実施例4記載の皮膚外用剤(実施例4処方)を指先にとり、目のまわり、口のまわり、鼻孔、生え際を避け、均一に広げる。
(2)そのまま5分間放置し、流水で約1分間を目安に、強くこすらないよう水かぬるま湯で十分に洗い流す。
(3)ついで、エッセンスをたっぷり含ませたマスクをしっかりと肌に密着させ、美容液成分を顔のすみずみにまで供給する。
(4)約10分後にマスクをはがし、夜用クリームを塗布する。
Example 11 (cosmetics kit)
A cosmetic kit comprising a daytime cream, a nighttime cream, an essence (moisturizing solution), a mask, and the external preparation for skin described in Example 4 was used. Day creams, night creams and essences are commercially available and commonly used.
This cosmetic kit contains an essence and day cream for morning care (morning operation 1), an essence and night cream for night care (night operation 1), or a skin external preparation and mask as described in Example 4. And night cream (night operation 2) are used.
As a method of use, apply after washing your face in the morning and evening. For morning care, perform morning operation 1 every day. For night care, perform night operation 2 every two days, such as night operation 2-night operation 1-night operation 1-night operation 2-night operation 1-night operation 1-night operation 2- The night operation 2 is performed about 4 times.
Moreover, the usage method of night operation 2 is as follows.
(1) Take the external preparation for skin described in Example 4 (formulation of Example 4) on the fingertip and spread it evenly around the eyes, around the mouth, nostrils and hairline.
(2) Leave for 5 minutes as it is, and rinse with running water or lukewarm water to avoid rubbing strongly, using running water for about 1 minute as a guide.
(3) Next, a mask containing plenty of essence is firmly attached to the skin, and the cosmetic liquid ingredients are supplied to the entire face.
(4) After about 10 minutes, remove the mask and apply night cream.
以下に、本発明の皮膚外用剤の処方例を挙げる。本発明はこの処方例によって何ら限定されるものではなく、特許請求の範囲によって特定されるものであることはいうまでもない。尚、配合量は全て製品全量に対する質量%で表す。 Below, the formulation example of the skin external preparation of this invention is given. Needless to say, the present invention is not limited by these formulation examples and is specified by the scope of claims. In addition, all compounding quantities are represented by the mass% with respect to the product whole quantity.
処方例1
(1)乳酸 3.0 質量%
(2)ジプロピレングリコール 5.0
(3)ダイナマイトグリセリン 1.0
(4)架橋型N,N−ジメチルアクリルアミド−2−アクリルアミド−2−メチルプロパンスルホン酸ナトリウム共重合体 1.3
(5)(PEG−240/デシルテトラデセス−20/HDI )コポリマー 1.0
(6)苛性カリ 1.0
(7)クエン酸ナトリウム 3.0
(8)グリチルリチン酸ジカリウム 0.05
(9)EDTA−2Na 0.02
(10)エタノール 3.0
(11)PEG−60水添ヒマシ油 0.3
(12)フェノキシエタノール 0.3
(13)香料 0.01
(14)酸化チタン 1.0
(15)精製水 残部
(製法)
(15)に(4)を溶解した後、(1)、(2)、(3)、(6)、(7)、(8)、(9)を溶解し、予め一部の精製水で(5)を加熱溶解したものを混合した。その後(10)に(11)、(12)、(13)を溶解混合し、(14)を分散した後、ろ過した。
Formulation Example 1
(1) Lactic acid 3.0% by mass
(2) Dipropylene glycol 5.0
(3) Dynamite glycerin 1.0
(4) Crosslinked N, N-dimethylacrylamide-2-acrylamido-2-methylpropanesulfonic acid sodium copolymer 1.3
(5) (PEG-240 / decyltetradeceth-20 / HDI) copolymer 1.0
(6) Caustic potash 1.0
(7) Sodium citrate 3.0
(8) Dipotassium glycyrrhizinate 0.05
(9) EDTA-2Na 0.02
(10) Ethanol 3.0
(11) PEG-60 hydrogenated castor oil 0.3
(12) Phenoxyethanol 0.3
(13) Fragrance 0.01
(14) Titanium oxide 1.0
(15) Remaining purified water (Production method)
After (4) is dissolved in (15), (1), (2), (3), (6), (7), (8), (9) are dissolved, and in advance with some purified water What was dissolved by heating (5) was mixed. Thereafter, (11), (12) and (13) were dissolved and mixed in (10), and (14) was dispersed, followed by filtration.
処方例2
(1)酒石酸 7.0質量%
(2)グリセリン 7.0
(3)1,3−ブチレングリコール 3.0
(4)架橋型N,N−ジメチルアクリルアミド−2−アクリルアミド−2−メチルプロパンスルホン酸ナトリウム共重合体 2.0
(5)(PEG−240/デシルテトラデセス−20/HDI )コポリマー 2.0
(6)L−アルギニン 0.5
(7)クエン酸ナトリウム 1.0
(8)苛性ソーダ 0.5
(9)EDTA−2Na 0.02
(10)エタノール 5.0
(11)酢酸トコフェロール 0.01
(12)PEG−60水添ヒマシ油 0.5
(13)フェノキシエタノール 0.3
(14)香料 0.01
(15)酸化チタン 2.0
(16)精製水 残部
(製法)
(16)に(4)を溶解し、(1)、(2)、(3)、(6)、(7)、(8)(9)を溶解し、予め一部の精製水で(5)を加熱溶解したものを混合した。その後(10)に(11)、(12)、(13)、(14)を溶解混合し、(15)を分散した後、ろ過した。
Formulation example 2
(1) Tartaric acid 7.0% by mass
(2) Glycerin 7.0
(3) 1,3-butylene glycol 3.0
(4) Crosslinked N, N-dimethylacrylamide-2-acrylamido-2-methylpropanesulfonic acid sodium copolymer 2.0
(5) (PEG-240 / decyltetradeceth-20 / HDI) copolymer 2.0
(6) L-arginine 0.5
(7) Sodium citrate 1.0
(8) Caustic soda 0.5
(9) EDTA-2Na 0.02
(10) Ethanol 5.0
(11) Tocopherol acetate 0.01
(12) PEG-60 hydrogenated castor oil 0.5
(13) Phenoxyethanol 0.3
(14) Fragrance 0.01
(15) Titanium oxide 2.0
(16) Purified water balance (Production method)
(4) is dissolved in (16), (1), (2), (3), (6), (7), (8) and (9) are dissolved, and (5) ) Was dissolved by heating. Thereafter, (11), (12), (13) and (14) were dissolved and mixed in (10), and (15) was dispersed and then filtered.
これら処方例1、2の本発明のケミカルピーリング用皮膚外用剤は、いずれも指取れのよさおよび洗い流しやすさに優れていた。 Each of these external preparations for chemical peeling of the present invention of Formulation Examples 1 and 2 was excellent in finger picking and ease of washing.
Claims (9)
(a)α−ヒドロキシ酸より選択される1種または2種以上を1.0〜7.0質量%
(b)架橋型N,N−ジメチルアクリルアミド−2−アクリルアミド−2−メチルプロパンスルホン酸ナトリウム共重合体を0.1〜3.0質量%
(c)下記の一般式(1)で表される化合物からなる会合性増粘剤を0.1〜3.0質量%
R1−{(O−R2)k−OCONH−R3[−NHCOO−(R4−O)n−R5]h}m …(1)
〔式中、R1は炭化水素基を表し、R2およびR4は互いに同一でも異なっても良い炭素数2〜4のアルキレン基、またはフェニルエチレン基を表し、R3はウレタン結合を有していても良い炭化水素基を表し、R5は分岐鎖または2級の炭化水素基を表し、mは2以上の数であり、hは1以上の数であり、kは1〜500の範囲の数,nは1〜200の範囲の数である。〕 A skin external preparation comprising the following (a) to (c), having a pH of 2.0 to 5.0, and being removed after application to the skin.
(A) 1.0-7.0 mass% of 1 type (s) or 2 or more types selected from alpha-hydroxy acid
(B) 0.1 to 3.0% by mass of a crosslinked N, N-dimethylacrylamide-2-acrylamido-2-methylpropanesulfonic acid sodium copolymer
(C) 0.1 to 3.0% by mass of an associative thickener comprising a compound represented by the following general formula (1)
R 1 -{(O-R 2 ) k-OCONH-R 3 [-NHCOO- (R 4 -O) n-R 5 ] h} m (1)
[Wherein R 1 represents a hydrocarbon group, R 2 and R 4 represent a C 2-4 alkylene group which may be the same or different from each other, or a phenylethylene group, and R 3 has a urethane bond. R 5 represents a branched or secondary hydrocarbon group, m is a number of 2 or more, h is a number of 1 or more, and k is in the range of 1 to 500. , N is a number in the range of 1 to 200. ]
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009153988A JP4608584B1 (en) | 2009-06-29 | 2009-06-29 | Skin preparation |
PCT/JP2010/004178 WO2011001633A1 (en) | 2009-06-29 | 2010-06-23 | External preparation for the skin |
CN201080029264XA CN102470085B (en) | 2009-06-29 | 2010-06-23 | External preparation for the skin |
HK12111955.6A HK1171188B (en) | 2009-06-29 | 2010-06-23 | External preparation for the skin |
KR1020117031106A KR101178097B1 (en) | 2009-06-29 | 2010-06-23 | External preparation for the skin |
EP10793807.8A EP2450029B1 (en) | 2009-06-29 | 2010-06-23 | External preparation for the skin |
US13/381,107 US8323629B2 (en) | 2009-06-29 | 2010-06-23 | External preparation for the skin |
TW099121310A TWI432218B (en) | 2009-06-29 | 2010-06-29 | Skin external use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009153988A JP4608584B1 (en) | 2009-06-29 | 2009-06-29 | Skin preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JP4608584B1 JP4608584B1 (en) | 2011-01-12 |
JP2011006371A true JP2011006371A (en) | 2011-01-13 |
Family
ID=43410723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009153988A Active JP4608584B1 (en) | 2009-06-29 | 2009-06-29 | Skin preparation |
Country Status (7)
Country | Link |
---|---|
US (1) | US8323629B2 (en) |
EP (1) | EP2450029B1 (en) |
JP (1) | JP4608584B1 (en) |
KR (1) | KR101178097B1 (en) |
CN (1) | CN102470085B (en) |
TW (1) | TWI432218B (en) |
WO (1) | WO2011001633A1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013515043A (en) * | 2009-12-22 | 2013-05-02 | ロレアル | Cosmetic composition containing jasmonic acid compound |
JP2015091782A (en) * | 2013-10-04 | 2015-05-14 | 御木本製薬株式会社 | Cosmetic |
JP2017066141A (en) * | 2015-09-30 | 2017-04-06 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドJohnson & Johnson Consumer Inc. | Compositions and methods for treating blackheads |
WO2019049722A1 (en) | 2017-09-07 | 2019-03-14 | 株式会社Adeka | Hair cosmetic composition containing aqueous gelling agent, and method for producing aqueous gelling agent and hair cosmetic composition |
WO2019049723A1 (en) | 2017-09-07 | 2019-03-14 | 株式会社Adeka | Skin- or hair-cleaning agent composition containing aqueous gelling agent, and method for producing aqueous gelling agent and cleaning agent composition |
WO2019049725A1 (en) | 2017-09-07 | 2019-03-14 | 株式会社Adeka | Cosmetic composition containing aqueous gelling agent, and method for producing aqueous gelling agent and cosmetic composition |
JP2021532142A (en) * | 2018-07-30 | 2021-11-25 | ロレアル | Two-step treatment for desquamation of the skin |
JP2022169261A (en) * | 2021-04-27 | 2022-11-09 | 株式会社 資生堂 | cosmetics |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140063627A (en) * | 2011-08-02 | 2014-05-27 | 가부시키가이샤 시세이도 | Oil-in-water-type emulsion cosmetic |
JP5373046B2 (en) | 2011-12-19 | 2013-12-18 | 株式会社 資生堂 | Oil-in-water emulsion composition |
WO2014092686A1 (en) * | 2012-12-11 | 2014-06-19 | Avon Products, Inc. | Stephanotis jasminoides extracts and methods of use |
US9186316B2 (en) | 2012-12-11 | 2015-11-17 | Avon Products, Inc. | Stephanotis jasminoides extracts and methods of use |
CN103705428B (en) * | 2014-01-10 | 2016-02-24 | 上海相宜本草化妆品股份有限公司 | For the nonionic composition and method of making the same of cutin of dispelling |
EP3193825A4 (en) * | 2014-09-08 | 2018-05-23 | Elementis Specialties, Inc. | Sulfate-free personal care compositions and methods |
EP3006016A1 (en) * | 2014-10-06 | 2016-04-13 | Medical Brands Research B.V. | Dermatological kit comprising compositions based on Hibiscus flower and Buriti oil |
JP6284894B2 (en) * | 2015-03-20 | 2018-02-28 | 富士フイルム株式会社 | Aqueous gel cosmetics |
JP6687341B2 (en) * | 2015-07-29 | 2020-04-22 | ロレアル | Compositions for keratin substances |
JP6903426B2 (en) * | 2016-12-15 | 2021-07-14 | ロレアル | Effervescent composition |
KR102269198B1 (en) * | 2019-10-16 | 2021-06-28 | 코스맥스 주식회사 | Vanishing cream cosmetic composition for exfoliation of skin and preparation method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002284664A (en) * | 2001-03-29 | 2002-10-03 | Shiseido Co Ltd | External skin preparation for whitening |
WO2003095583A1 (en) * | 2002-05-14 | 2003-11-20 | Shiseido Company, Ltd. | Thickener, cosmetic preparation containing the same, and process for producing the same |
JP2005068023A (en) * | 2003-08-26 | 2005-03-17 | Shiseido Co Ltd | Skin care preparation for external use |
WO2005117810A1 (en) * | 2004-06-04 | 2005-12-15 | Shiseido Co., Ltd. | External preparation for the skin |
JP2006062996A (en) * | 2004-08-25 | 2006-03-09 | Shiseido Co Ltd | Hair cosmetics |
WO2008018541A1 (en) * | 2006-08-09 | 2008-02-14 | Shiseido Company Ltd. | Oil-in-water-type emulsion composition |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE177629T1 (en) | 1991-04-10 | 1999-04-15 | Yu Ruey J | USE OF COMPOSITIONS CONTAINING 2-HYDROXYCARBONIC ACID OR DERIVATIVES THEREOF FOR RELIEVING OCEAN NAIL CHANGES |
US5422112A (en) | 1994-06-09 | 1995-06-06 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Thickened cosmetic compositions |
JPH10218753A (en) | 1995-03-24 | 1998-08-18 | Sunstar Inc | Skin cosmetic composition |
WO2001017487A1 (en) | 1999-09-06 | 2001-03-15 | Setsuko Ueda | Chemical peeling agent |
TWI308579B (en) * | 2001-03-02 | 2009-04-11 | Shiseido Co Ltd | Cosmetics containing an aqueous polymer emulsion |
JP3708531B2 (en) * | 2002-05-14 | 2005-10-19 | 株式会社資生堂 | Thickener and cosmetics containing the same |
US20050249763A1 (en) * | 2004-04-19 | 2005-11-10 | L'oreal | Kit for formulating a cosmetic product |
FR2886300B1 (en) * | 2005-05-25 | 2007-06-29 | Seppic Sa | NEW REVERSE LATEX OF COPOLYMERS OF AMPS AND NN-DIMETHYL ACRYLAMIDE; USE IN COSMETICS |
FR2888494B1 (en) * | 2005-07-13 | 2014-03-14 | Oreal | USE OF UREA COMPOUNDS TO PROMOTE DESQUACATION |
US7723387B2 (en) * | 2006-06-28 | 2010-05-25 | Polymer Surfaces Group, Llc | Self-neutralizing acid peel for dermatologic use |
US20080293826A1 (en) * | 2007-05-21 | 2008-11-27 | Conopco, Inc., D/B/A Unilever | Cosmetic compositions with ethoxylated urethane |
DE502008001538D1 (en) * | 2007-05-23 | 2010-11-25 | Basf Se | ISOTAKTIC POLYSTYRENE WITH REACTIVE GROUPS |
JP4616327B2 (en) | 2007-12-19 | 2011-01-19 | 株式会社ブルーム・クラシック | Peeling cosmetic and method for using the same |
-
2009
- 2009-06-29 JP JP2009153988A patent/JP4608584B1/en active Active
-
2010
- 2010-06-23 CN CN201080029264XA patent/CN102470085B/en active Active
- 2010-06-23 WO PCT/JP2010/004178 patent/WO2011001633A1/en active Application Filing
- 2010-06-23 US US13/381,107 patent/US8323629B2/en active Active
- 2010-06-23 KR KR1020117031106A patent/KR101178097B1/en not_active Expired - Fee Related
- 2010-06-23 EP EP10793807.8A patent/EP2450029B1/en active Active
- 2010-06-29 TW TW099121310A patent/TWI432218B/en not_active IP Right Cessation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002284664A (en) * | 2001-03-29 | 2002-10-03 | Shiseido Co Ltd | External skin preparation for whitening |
WO2003095583A1 (en) * | 2002-05-14 | 2003-11-20 | Shiseido Company, Ltd. | Thickener, cosmetic preparation containing the same, and process for producing the same |
JP2005068023A (en) * | 2003-08-26 | 2005-03-17 | Shiseido Co Ltd | Skin care preparation for external use |
WO2005117810A1 (en) * | 2004-06-04 | 2005-12-15 | Shiseido Co., Ltd. | External preparation for the skin |
JP2006062996A (en) * | 2004-08-25 | 2006-03-09 | Shiseido Co Ltd | Hair cosmetics |
WO2008018541A1 (en) * | 2006-08-09 | 2008-02-14 | Shiseido Company Ltd. | Oil-in-water-type emulsion composition |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013515043A (en) * | 2009-12-22 | 2013-05-02 | ロレアル | Cosmetic composition containing jasmonic acid compound |
JP2015091782A (en) * | 2013-10-04 | 2015-05-14 | 御木本製薬株式会社 | Cosmetic |
JP2017066141A (en) * | 2015-09-30 | 2017-04-06 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドJohnson & Johnson Consumer Inc. | Compositions and methods for treating blackheads |
KR20200051677A (en) | 2017-09-07 | 2020-05-13 | 가부시키가이샤 아데카 | A detergent composition for skin or hair containing an aqueous gelling agent, and a method for producing the aqueous gelling agent and the cleaning agent composition thereof |
WO2019049723A1 (en) | 2017-09-07 | 2019-03-14 | 株式会社Adeka | Skin- or hair-cleaning agent composition containing aqueous gelling agent, and method for producing aqueous gelling agent and cleaning agent composition |
WO2019049725A1 (en) | 2017-09-07 | 2019-03-14 | 株式会社Adeka | Cosmetic composition containing aqueous gelling agent, and method for producing aqueous gelling agent and cosmetic composition |
WO2019049722A1 (en) | 2017-09-07 | 2019-03-14 | 株式会社Adeka | Hair cosmetic composition containing aqueous gelling agent, and method for producing aqueous gelling agent and hair cosmetic composition |
KR20200051671A (en) | 2017-09-07 | 2020-05-13 | 가부시키가이샤 아데카 | A hair cosmetic composition containing an aqueous gelling agent, and a method for producing the aqueous gelling agent and a hair cosmetic composition thereof |
KR20200051678A (en) | 2017-09-07 | 2020-05-13 | 가부시키가이샤 아데카 | A cosmetic composition comprising an aqueous gelling agent, and a method for producing the aqueous gelling agent and its cosmetic composition |
US11464730B2 (en) | 2017-09-07 | 2022-10-11 | Adeka Corporation | Cosmetic composition containing aqueous gelling agent, and method for producing aqueous gelling agent and cosmetic composition |
US11771632B2 (en) | 2017-09-07 | 2023-10-03 | Adeka Corporation | Skin- or hair-cleansing composition containing aqueous gelling agent, and methods for producing aqueous gelling agent and cleansing composition |
JP2021532142A (en) * | 2018-07-30 | 2021-11-25 | ロレアル | Two-step treatment for desquamation of the skin |
JP7317941B2 (en) | 2018-07-30 | 2023-07-31 | ロレアル | Two-stage treatment for skin desquamation |
JP2022169261A (en) * | 2021-04-27 | 2022-11-09 | 株式会社 資生堂 | cosmetics |
Also Published As
Publication number | Publication date |
---|---|
EP2450029A1 (en) | 2012-05-09 |
US8323629B2 (en) | 2012-12-04 |
EP2450029B1 (en) | 2013-12-25 |
KR20120023136A (en) | 2012-03-12 |
TW201114444A (en) | 2011-05-01 |
CN102470085A (en) | 2012-05-23 |
US20120183492A1 (en) | 2012-07-19 |
CN102470085B (en) | 2013-08-21 |
EP2450029A4 (en) | 2012-11-21 |
WO2011001633A1 (en) | 2011-01-06 |
KR101178097B1 (en) | 2012-08-30 |
JP4608584B1 (en) | 2011-01-12 |
HK1171188A1 (en) | 2013-03-22 |
TWI432218B (en) | 2014-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4608584B1 (en) | Skin preparation | |
JP2008231010A (en) | External preparation for skin | |
TWI412543B (en) | Alkylene oxide derivative and external skin preparation containing same | |
JP2009073932A (en) | Oligomer ester and composition | |
JP6313961B2 (en) | Oil-in-water emulsion composition | |
KR100826503B1 (en) | Skin external preparations | |
JP2002284664A (en) | External skin preparation for whitening | |
JP5121527B2 (en) | Topical skin preparation | |
JP2011006372A (en) | Beauty treatment | |
JP5398129B2 (en) | Skin metabolism promoter | |
JP2005281133A (en) | Skin care preparation for external use | |
AU2016261772B2 (en) | Copolymer | |
JP6609437B2 (en) | Oil-in-water emulsified composition | |
JP2005281135A (en) | Skin care preparation for external use | |
JP4515109B2 (en) | Skin external preparation and fiber having a lipolysis promoting effect | |
WO2021215423A1 (en) | Cosmetic preparation | |
TW202203894A (en) | Oil-in-water type cosmetic emulsion preparation | |
JP2009149557A (en) | Skin amelioration agent | |
JP2012219122A (en) | Novel silicone derivative | |
JP2005281134A (en) | Skin care preparation for external use | |
JP2006008630A (en) | Skin preparation for external use | |
WO2021215211A1 (en) | Cosmetic | |
WO2023100682A1 (en) | Cosmetic | |
JP2013129721A (en) | Novel silicone derivative | |
JP2013213171A (en) | New silicone derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20101005 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20101008 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4608584 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131015 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |